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The integrity of the male reproductive system is essential in order to ensure the future 
well-being of a species. This study aimed to determine whether cigarette smoking 
and/or low antioxidant levels are associated with damage to human spermatozoa that 
may result in offspring pathology and reduced male fertility.
Using the sperm chromatin structure assay and the terminal deoxynucleotidyl 
transferase assay, it was determined that smokers’ sperm were significantly more 
sensitive to acid induced denaturation and possessed higher levels of DNA strand 
breaks than non-smokers’ sperm. In addition, sperm from donors who smoked 
possessed more YY1 aneuploid sperm compared to non-smokers. These differences 
may predispose offspring of paternal smokers to greater risk of disease and 
malformations. The total antioxidant activity of seminal plasma from smokers was 
also significantly lower than that of non-smokers.
Sperm preparation techniques, such as centrifugation, commonly used prior to in vitro 
fertilisation and scientific studies, are associated with spermatozoal damage. It was 
demonstrated that the induction by hydrogen peroxide of spermatozoal DNA strand 
breaks and lipid peroxidation was reduced by the presence of seminal plasma. The 
results indicate that maintaining sperm in seminal plasma might decrease the potential 
for cellular damage to arise and allow for an improvement in semen quality used for 
artificial insemination and scientific research.
The human epididymis provides an optimal environment for the storage and 
maturation of spermatozoa. However, extra-epididymal spermatozoa account for 
approximately a third of all sperm cells found in the normal human ejaculate. Data 
from the study determined that sperm living outside of the epididymis express an 
abnormal chromatin structure, by comparing sperm from patients after vasectomy to 
normozoospermic donors. It was also demonstrated that the epididymis possesses 
region-specific antioxidant activity, which may protect sperm from oxidative attack 
during storage at this site.
Supercritical fluid technology allowed the development of a novel method to extract 
cotinine, a nicotine metabolite, and caffeine, from semen. HPLC and GC-MS were 
used to identify the compounds. GC-MS also allowed the identification of several
III
hydrocarbons in seminal fluid, including an aromatic hydrocarbon, that may have 
toxicological implications. Coenzyme Q10, an antioxidant and component of the 
respiratory chain, was also measured in spermatozoa and seminal plasma. 
Spermatozoal levels of coenzyme Q10 correlated with sperm count, motility and 
normal morphology, but was found at equal levels in samples obtained from smokers 
and non-smokers.
It is hoped that the data obtained in the study will enable advancement in the 
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The reproductive system enables the perpetuation of a species. The survival of an 
organism is dependent on the integrity of this system which is essential in order to 
ensure the flawless flow of genetic material from generation to generation. It is 
estimated that approximately twenty percent of couples are involuntary sterile and 
around fifteen percent of recognised pregnancies spontaneously abort (Thomas 1996). 
The impact of chemicals on the reproductive system is, therefore, an important area 
of research due to the adverse effects of many such chemicals, causing, for example, 
reduced fertility and genetic damage to the gametes.
1.1 Physiology of the Male Reproductive Tract
The male gonads possess two functions; firstly, the synthesis and secretion of sex 
hormones, predominantly testosterone and dihydrotestosterone, and secondly, 
gametogenesis, or the production of germ cells. Both functions are dependent on the 
secretions of the anterior pituitary gland, namely follicle-stimulating hormone (FSH) 
and luteinizing hormone (LH). The secretion of FSH and LH is stimulated by the 
release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. FSH 
stimulates spermatogenesis by binding to a receptor located on the Sertoli cells. This 
causes the Sertoli cells to secrete a host of hormones and proteins that stimulate germ 
cell production. LH increases the rate of testicular steroidogenesis. The release of 
GnRH, FSH and LH is inhibited by hormonal products of the testes, such as 
testosterone; a process termed 'negative feedback'.
1
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1.1.1 Spermatogenesis: the Production of Sperm
Spermatogenesis is the process whereby male germ cells, or spermatozoa, are 
produced within the germinal epithelia (Amann 1989). Each day, the germinal 
epithelia must produce millions of spermatozoa from primitive germ cells, the 
spermatogonia. Of the two major types of spermatogonia, type A generate more 
spermatogonia. Type B spermatogonia go on to become mature spermatozoa through 
a multi-step process, as depicted in fig. 1.1. Once the testes have fully matured upon 
puberty, the type B spermatogonia develop into primary spermatocytes, which divide 
through meiotic cell division to become secondary spermatocytes and then 
spermatids. Meiotic cell division results in a halving of the normal complement of 
chromosomes; from a diploid cell to a haploid cell. Spermatids complete their 
development into spermatozoa through extensive nuclear and cytoplasmic 
reorganisation (Bedford 1979; Balhom 1989). The nucleus containing the cell’s 
genetic material, condenses and becomes the sperm head. This process occurs as the 
nuclear histones are replaced by arginine/cysteine-rich protamines, which allows 
chromatin stabilisation through intra- and inter-protamine cross-linking via disulphide 
bridges. This produces a highly condensed sperm nucleus whose volume is only 1 :
100,000 that of an ovum, and which is more resistant to DNA cleavage and 
denaturation and in situ enzymatic degradation than a somatic cell. In addition, the 
two centrioles form the flagellum, and mitochondria migrate to a sheath situated 
nearby the flagellum. Both the mitochondria and flagellum enable sperm cell 
motility. Part of the Golgi apparatus also moves to the head of the cell into the 
acrosome region; a process required for penetration of the oocyte at fertilisation.
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Fig. 1.1. The production of spermatozoa, or spermatogenesis. The numbers and letters next to each 
cell represents the chromosome compliment of the cell. For example, 44xy denotes a cell possessing 
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The process of spermatogenesis occurs within the seminiferous tubules, which are 
represented in fig. 1.2. Found within the interstitium of the tubules are the Leydig 
cells, the primary site of male testosterone synthesis (Ewing 1992). Conversely, the 
germ cells and Sertoli cells are located within the membranous boundaries of the 
seminiferous tubules. The integrity of the Sertoli cells is essential for normal 
spermatogenesis (Thomas 1996). The Sertoli cells secrete several key hormones and 
proteins such as inhibin, which modulates pituitary FSH secretion, and androgen- 
binding protein that acts as a carrier of testosterone and dihydrotestosterone. In 
addition, the Sertoli cell junctions aid in the formation of the blood-testes barrier.
4
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Following spermatogenesis, the sperm are expelled from the testes into the 
epididymis through the efferent ducts by way of the rete testes. Prior to ejaculation, 
several post-testicular secretions are added to the sperm, which when combined, 
produces seminal fluid or semen.
1.1.2 Accessory Sex Organs
A number of organs, known as the accessory sex organs (see fig. 1.3), contribute to 
the post-testicular processes. The seminal plasma transports the ejaculated sperm 
from the male to the female reproductive tract. The secretory organs, including the 
epididymides, prostate, seminal vesicles, bulbourethral (or Cowper’s) glands, and 
urethral (or Littre’s) glands, produce the seminal plasma. Abnormal function of any 
of the secretory organs may be reflected in an alteration of the characteristics of the 
seminal plasma (Thomas 1996).
The human ejaculate is produced sequentially (Thomas 1996). The first portion of 
the ejaculate, or pre-sperm fraction, is comprised of secretions produced by the 
urethral and Cowper’s glands. The sperm-rich fraction then follows, and contains 
prostatic secretions and the spermatozoa. Finally, the seminal vesicle secretion is 
delivered, comprising the post-sperm portion. There is a considerable overlap 
between the pre-sperm, sperm-rich, and post-sperm fractions. It is, therefore, very 




Fig. 1.3. Anatomical arrangement of the male reproductive tract, including the accessory sex organs 























Several biochemical markers exist for the accessory gland secretions (WHO 1992). 
The prostatic secretion in men and many other mammals is indicated by acid 
phosphatase, zinc and citric acid, whereas fructose is a marker for active seminal 
vesicle secretion. About two-thirds of the total human ejaculate is contributed by the 
seminal vesicles and the other third by the prostate.
The World Health Organisation (WHO) publishes criteria that should be met by a 
sample in order for it to be considered ‘normozoospermic’, or ‘normal’ (WHO 1992), 
which is shown in table 1.1. In order for a semen sample to be considered 
normozoospermic, the specimen should possess a minimal sperm cell concentration 
of 20 x 106/ml, a minimum forward progressive motility of 50 % and greater than 30 
% of cells with a normal morphology.
8
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PH 7.2 - 8.0
Sperm concentration > 20 x 106 sperm/ml
Total sperm count > 40 x 106 sperm/ejaculate
Motility > 50 % with forward progression within 60 minutes of
ejaculation
Morphology > 30 % with normal morphology
Vitality >15%  live, i.e., excluding dye
White blood cells < 1 x 106/ml
Optional tests
a-Glucosidase (neutral) > 20 mU per ejaculate
Zinc (total) >2.4 pmol per ejaculate
Citric acid (total) > 52 pmol per ejaculate
Acid phosphatase (total) > 200 mU per ejaculate
Fructose (total) >13 pmol per ejaculate
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In addition to the WHO criteria, a series of nomenclature has been introduced that 
enables the delineation of differing fertility groups amongst men (Eliasson et ah, 
1970; table 1.2)
Table 1.2. Nomenclature describing semen variables in man (source: Eliasson et ai., 1970).
Category Semen characteristics
Normozoospermia Normal ejaculate as defined in table 1.1
Oligozoospermia Sperm concentration < 20 x 106/ml
Asthenozoospermia <50%  sperm with forward progression
T eratozoospermia < 30 % sperm with normal morphology
Oligoasthenoteratozoospermia Signifies disturbance of all three
categories
(combinations of only two prefixes may
also be used)
Azoospermia No sperm in the ejaculate
Aspermia No ejaculate
1.1.3 Erection and Ejaculation
Both the central nervous system (CNS) and autonomic nervous system (ANS) control 
erection and ejaculation. An erection results from dilation of the arterioles of the 
penis. Ejaculation is a spinal reflex involving multi-glandular secretion, movement of
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semen into the urethra, and ejaculation, or propulsion of the semen out of the urethra 
at the point of orgasm.
1.1.4 The Blood-Testes Barrier
The body contains a number of specialised anatomical barriers in the body, such as 
the blood-brain barrier and the blood-thymus barrier. In males, there also exists the 
blood-testes barrier. The blood-testes barrier is located somewhere between the 
lumen of an interstitial capillary and the lumen of a seminiferous tubule (Neaves 
1977). It was first demonstrated by Setchell and co-workers (1969) that 
immunogoblins and iodinated albumin, inulin, and a number of small molecules were 
excluded from the seminiferous tubules by the blood testes-barrier. The capillary 
endothelium, the capillary basal lamina, the basal lamina of the seminiferous tubule, 
the Sertoli cells and the lymphatic endothelium are among the anatomical structures 
that intervene between the two luminal spaces. The barrier inhibits the free exchange 
of nutrients, hormones and chemicals into the lumen of the seminiferous tubule, 
where the germ cells are concentrated. The anatomical relationships of the blood- 
testes barrier may be even less developed in the immature or young mammalian 
testes, thereby allowing more, potentially detrimental, foreign chemicals to permeate 
the seminiferous tubule (Thomas 1996).
1.2 Toxic Responses of the Reproductive System
The developing gonad is very sensitive to chemical affront. In addition, the embryo 
is also sensitive to environmental disturbance. A concern for hazards to the
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reproductive system can be traced back to the Roman Empire (Gilfillan 1965). The 
increased incidence of stillbirths was most likely a consequence of the high 
concentration of lead in pottery and water vessels. Lead is an abortifacient and is 
capable of producing teratospermias.
The last century has seen an enormous explosion in the number of chemicals one may 
be exposed too, with approximately 600 new chemicals entering commerce each year 
(Thomas 1996). Corresponding with the rise of the industrial production of 
chemicals, there has been an increase in endocrine disorders and occupational 
diseases (Thomas 1996). The thalidomide episode in the 1960s demonstrated the 
impacts of new chemicals on the reproductive system (Fabrio 1985). The incident led 
to an increase in awareness of the fragility of the reproductive system and the 
potential dangers that may arise upon exposure to chemical toxins in the work place. 
Since World War II, increasing amounts of chemicals dangerous to the endocrine 
system have been released into the environment, and research suggests that exposure 
to endocrine-disrupting chemicals leads to health difficulties in a variety of animal 
species (Colburn et al., 1993). For example, demasculisation and defeminisation has 
been observed in fish, gastropods and birds, whilst in the presence of endocrine- 
disrupting chemicals. The reproductive system of mammals and non-mammals may 
also be affected by oestrogens present as natural components in the diet, in addition to 
environmental oestrogens (Thomas 1996).
While concerns regarding reproductive hazards have existed for centuries, most 
epidemiologic and reproductive factors have concentrated on maternal factors 
(Olshan and Faustman, 1993). It is only recently that the influence of chemical
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perturbation of the male reproductive system have been studied. It has become 
increasingly obvious that reproductive toxicity involves both the female and male of 
the species (Mattison et al., 1990).
It is difficult to assess the specific potential hazards that chemicals pose to 
reproduction because of the complexity of the reproductive process, the unreliability 
of laboratory tests due to, for example, extrapolation of animal experiments, and the 
poor quality of human data. Human beings do, however, face numerous 
abnormalities in the reproductive system. For example, it is estimated that one in five 
couples are involuntarily sterile, over one-third of early embryos die, and about 
fifteen percent of recognised pregnancies abort spontaneously. Amongst the foetuses 
that survive, approximately three percent have developmental defects at birth, 
although not always anatomic. As the child ages, another six percent develop 
detectable defects (Thomas 1996). The above findings indicate that the reproductive 
system does not function in an optimal state even under normal physiological 
conditions. The introduction of chemicals or drugs can therefore farther impede on a 
number of biological processes or events.
The human gonad is capable of the biotransformation of exogenous chemicals that 
have traversed the blood-testes barrier (Thomas 1996). For example, the primary 
hepatic biotransforming enzymes, the cytochrome P450 family, that are also 
implicated in the activation of many chemicals into toxic metabolites, have been 
located in testicular microsomes (Parkinson 1996). This has important toxicological 
implications, as many compounds are not toxic unless they are first metabolised, or 
activated, into a different species.
13
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The consequence of toxic insult on the gonads is often an interference with 
steroidogenesis or spermatogenesis. For example, diethylhexyl phthalate and other 
plasticisers, produce a depletion of testicular zinc and subsequent reduction in 
spermatogenesis, as well as testicular atrophy (Thomas and Thomas, 1984). 
Metabolites of the fungicide, vinclozolin, act as antagonists of the androgen receptor 
(Kelce et al., 1994). The activation of 2-methoxyethanol by alcohol and aldehyde 
dehydrogenases to the toxin, 2-methoxyacetic acid, results in a reduction in 
spermatogenesis (Mebus et al., 1989). To date, however, little is known with regards 
to the effects of chemicals on erection or ejaculation. It has been determined that 
pesticides, particularly organophosphates, affect neuroendocrine processes involved 
in erection and ejaculation. Many drugs also produce impotence in humans, and 
include ethanol, hypotensives and hormones such as estrogens (Millar 1979). 
Occupational exposure also contributes to human male reproductive tract toxicity. 
Heavy metal exposure commonly correlates with reproductive pathology. For 
instance, lead causes reduced fertility and increased risk of offspring miscarriages and 
stillbirths (Thomas and Brogan, 1983). Lead also suppresses the hypothalamic- 
pituitary-testicular axis, thus interfering with the regulation of steroid levels (Klein et 
al.,1994).
It becomes apparent that a vast array of chemicals adversely affect the male 
reproductive system and that the sites and mechanisms of action differ greatly. This 
produces great difficulty in assessing the toxicity of a compound on reproductive 
function. Several tests are currently in use that allow the functional assessment of the 
male reproductive system. The majority of the tests are unacceptable for use in
14
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humans due to the invasive nature of the assays. Table 1.3 shows a range of tests 
used to assess male reproductive health in animals and/or man.
15
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Table 1.3. Some tests used to assess male reproductive toxicology in humans and/or animals (Source: 
Thomas 1996).
Reproductive Parameter Test
Fertility Number of embryos per pregnant female 
Sperm per ovum
Ratio exposed : pregnant females
Testes Weight, shape or size 
Histology 
Spermatid reserves
Epididymis Weight and histology
Number, motility and morphology of
sperm at distal end
Semen Volume
Sperm concentration/number, motility 
and morphology
Sperm Motility Multiple exposure photography 
Videomicrography
Computer Aided Sperm Assessment 
(CASA)
Cervical mucus penetration test
Endocrine Luteinizing hormone (LH)




The use of animals and subsequent extrapolation of data to humans represents an 
uncertainty due to differences in the handling, such as absorption and metabolism, 
and response to a chemical. Human studies are restricted depending on the toxicity of 
the compound in question; therefore, epidemiology studies are frequently sought to 
determine whether a relationship exists or not between exposure to a toxin and an 
adverse effect. Programs that monitor people at risk, for example industrial workers, 
also allow for the establishment of safer working conditions.
1.3 Important Consequences of Damage to the Reproductive System
1.3.1 DNA Damage
DNA attack, for example by free radicals, results in many chemical changes to DNA 
itself (Halliwell and Gutteridge, 1999). The production of strand breaks can arise 
following the exposure of DNA to reactive oxygen species (ROS). For instance, 
exposing DNA to ionising radiation, cigarette smoke and H20 2 produces strand 
breaks in many cell types (Halliwell and Gutteridge, 1999). In addition, ROS can 
produce oxidative base damage to DNA. Many methods have been detected for the 
measurement of several of these products, including 8-hy droxy-2' -deoxy guano sine 
and thymine glycol, that enable the measurement of basal levels of oxidative DNA 
damage and also induced production of base damage after exposure to a toxin.
1.3.2 DNA Damage and the Generation o f Genetic Damage
Genetic damage usually results from either gene mutations, chromosome aberrations, 
or changes in chromosome number.
17
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Damage to DNA can result in mutations, either due to direct exposure to a toxin or 
during attempts by a cell to repair or replicate the damaged DNA (Halliwell and 
Gutteridge, 1999). Mutations to genes are changes in the DNA sequence of a gene; 
the principal forms being base-pair substitutions and frameshift mutations (Hoffmann 
1996), as depicted in fig. 1.4. In a base-pair substitution, one base pair in DNA is 
replaced by another. The substitutions can be either transitions, whereby, for 
example, a purine is replaced by another, or a transversion, whereby a purine is 
replaced by a pyrimidine for instance. The transition or transversion may result in a 
missense in protein synthesis, where a coding change causes an amino acid to be 
replaced by another. Alternatively, a nonsense mutation may result, where the gene 
product is incomplete and non-functional due to the premature termination of protein 
synthesis. Overall, a mutation can inactivate the gene, can only have a slight effect 
on the gene or have no effect at all.
Frameshift mutations occur when the reading frame of the genetic code is altered 
during the translation of RNA into protein. Most frequently, frameshifts involve the 
loss or gain of one or two base pairs in a gene. The gene product involving a 
frameshift mutation is invariably grossly altered as every triplet in the messenger 
RNA is changed after the point of the mutation. In addition, the gene product is also 
likely to be incomplete because the new reading frame is likely to include a nonsense 
codon, namely UAA, UAG or UGA, which specifies no amino acid at all. Frameshift 
mutations generally result in non-functional gene products. Phenotypically, the 
consequences of a frameshift mutation will depend on how the organism is affected 
by the loss of that specific genes product.
18
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Fig. 1.4. Base-pair substitutions and frameshift mutations in DNA (source: Hoffmann 1996). Arrows 
indicate the site o f DNA mutagenesis. In this instance, the base-pair substitutions are a transversion 
(G:C -»  T:A), resulting in a nonsense mutation, and a transition (G:C -> A:T), that results in a 
missense mutation. The frameshift mutations shown are examples in which one base pair (G:C) has 
been added (+1 frameshift) or two base-pairs (G:C and C:G) have been deleted (-2 frameshift). The 
frameshift mutations alter the reading frame of the genetic code for all codons after the point o f the 
mutation.
G:C T:A Transversion
...TTA GGG GAC GCG CAT TAA.... 
....AAT CCC CTG CGC GTA ATT. ..
G:C A T  Transition
Encodes no amino acid
.. TTA GAG GAC GCG CAT GAA.... 
AAT CTC CTG CGC GTA CTT...
Encodes wrong amino acid
TTA GGG GAC GCG CAT GAA. .. 
AAT CCC CTG CGC GTA CTT. ..
Nonmutant sequence
+1 Frameshift
TTA GGG GGA CGC GCA TGA A. .. 
AAT CCC CCT GCG CGT ACT T. ..
Encode wrong amino acids-l
E ncodes no amino acid
-2 Frameshift
TTA GGG GAC GCA TGA A.. 
AAT CCC CTG CGT ACT T. ..
I I I
Encodes wrong amino acid-l
Encodes no amino acid
19
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Changes in chromosome structure that involve large alterations in the genetic material 
are termed chromosomal aberrations. Damage may include chromosome breakage or 
chromosome breakage and subsequent rearrangement. Most aberrations are unstable 
and result in the death of the cell, although some persist and are transmitted as cell 
division occurs.
Aneuploidy and polyploidy represent the cellular consequences of changes in 
chromosome number. Aneuploidy involves a deviation from the normal diploid 
number, whereas polyploidy involves a complete loss or gain of a set of 
chromosomes. For example, a human somatic cell possessing 47 chromosomes 
would be defined as aneuploid. A cell possessing 69 chromosomes would be said to 
be polyploid, in this instant triploid, or three times the haploid number.
The adverse consequences of gene mutations in germ cells is evident from the 
number of genetically inherited diseases. Around 1.3 % of neonates are bom with 
autosomal dominant (~1 %), autosomal recessive (~0.25 %) or sex-linked (~0.05 %) 
genetic diseases (Sankaranarayanan 1993). As well as inherited disease, gene 
mutations can produce congenital abnormalities and increased frequencies of foetal 
death during development (Sankaranarayanan 1993). Chromosomal abnormalities 
can also result in foetal death or serious disease states.
1.3.3 Lipid Peroxidation
Lipid peroxidation occurs when polyunsaturated lipids become damaged due to 
oxidative stress (Halliwell and Gutteridge, 1999). The major constituents of 
biological membranes are protein and lipid, with the lipid component commonly
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containing polyunsaturated side-chains (Halliwell and Gutteridge, 1999). The 
oxygen-dependent process of lipid peroxidation results in lipid rancidity; organisms, 
therefore, must be adequately protected against such phenomena.
1.3.4 The Production of Lipid Peroxidation: Initiation and Propagation
The sequence leading to lipid peroxidation in biological systems is a multi-step 
process, ultimately resulting in the generation of detrimental lipid peroxides (see 
Halliwell and Gutteridge, 1999).
Initiation of lipid peroxidation occurs with the extraction of a hydrogen atom from a 
methylene group in a polyunsaturated fatty acid by a sufficiently active species, such 
as a hydroxyl radical:
-CH2-  + OH* -> -*CH- + H20
the removal of a hydrogen from a methyl group leaves behind an unpaired electron on 
the carbon. The presence of a double bond in the lipid reduces the C-H bonds on the 
carbon atom adjacent to the double bond, thus aiding removal of the hydrogen atom. 
The formed carbon radical usually becomes stabilised by a molecular rearrangement, 
producing a conjugated diene. The most common fate of the carbon radical in an 
aerobic system is to react with oxygen to produce a peroxyl radical, ROO*:
R* + 0 2 -» ROO*
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The peroxyl radical is then able to extract a hydrogen atom from another lipid 
molecule, resulting in the propagation of lipid peroxidation:
ROO* + CH -> -ROOH + C*
The carbon radical so formed can now react further with oxygen to form another 
peroxyl radical, and so the chain reaction continues.
The peroxyl radicals formed during the propagation steps combines with the 
hydrogen atom it abstracts to produce a lipid peroxide. In addition to the formation 
of deleterious lipid peroxides, two end-products of lipid peroxidation, 
malondialdehyde and 4-hydroxy-2-nonenal, are known to produce mutagenic DNA 
adducts (Halliwell and Gutteridge, 1999). An example of the generation of lipid 
peroxidation in a fatty acid with three double bonds is provided in fig. 1.5.
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Fig. 1.5. Proposed mechanism for the production of lipid peroxides from a fatty acid possessing three 
double bonds (source: Halliwell and Gutteridge, 1999).
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Antioxidants are well established in the biological sciences as playing a crucial role in 
the reduction of oxidative attack. An antioxidant can be defined as ‘any substance 
that, when present at low concentrations compared to that of an oxidisable substrate, 
significantly delays or inhibits oxidation of that particular substrate’ (Halliwell and 
Gutteridge, 1999). Antioxidants are of importance because oxidation of a substrate 
and the production of electrophiles and radical species, toxic intermediates, can lead 
to binding by the reactive compound to critical nucleophiles, such as nucleic acids 
and proteins, and produce genetic and other cellular damage. Biological actions of 
antioxidants include scavenging initiating radical species and also intermediate 
radical species; the latter being so-called chain-breaking antioxidants because of their 
capability to prevent further hydrogen abstraction and continued radical formation. 
Many enzymes also act alone and in combination to detoxify radicals. The modes of 
action of several important antioxidants will now be discussed.
1.4.1 Glutathione
Glutathione (GSH) is a thiol containing tripeptide, composed of a cysteine (Cys), 
glutamic acid (Glu) and glycine (Gly) residue, as depicted in fig. 1.6.
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Fig. 1.6. Structure of glutathione in both its reduced (GSH) and oxidised (GSSG) form (source: 
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GSH detoxifies radical species by donating hydrogen atoms and reducing 
compounds; and by forming conjugates, catalysed by the family of enzymes, 
glutathione ^-transferases, although non-enzymic conjugation does also occur, albeit 
at a much slower rate (Parkinson 1996). An example of a typical detoxification 
reaction by GSH is depicted in fig. 1.7.
Fig. 1.7. A typical detoxification reaction performed by glutathione (GSH) (source: Gregus and 
Klaassen, 1996). In this instance, peroxidase (POD) metabolism of chlorpromazine (CPZ) produces a 
free radical species, CPZ**. GSH detoxifies the free radical by the donation of an electron. The 
glutathione thiyl radical (GS*) combines with another GS* spontaneously, forming glutathione 





GSH reduces the reactive species and becomes its oxidised form, GSSG, whereby 
two GSH molecules are joined to produce a disulphide bridge (fig. 1.6). The ratio of 
GSH : GSSG is kept high in vivo; this is accomplished via the enzyme glutathione 
reductase (GRD), which regenerates GSH by the reaction below:
GSSG + NADPH + H+->2 GSH + NADP+
GSH is present in animals and plants, as well as certain bacteria, often at millimolar 
concentrations in certain tissues such as the liver. In human seminal plasma, GSH is 
present at a concentration of 0.5 pM (Li 1975; Ochsendorf et al., 1998). The 
compound is also present in very small amounts in human spermatozoa, at levels of
o
around 3 nmol/10 spermatozoa (Li 1975; Ochsendorf et al., 1998).
1.4.2 Ascorbic acid
Ascorbic acid, or vitamin C, is a water soluble solid, that many plants and animals 
can synthesise in vivo. Man, however, is not able to produce the compound and is, 
therefore, reliant on ascorbic acid to be present in the diet. Fig. 1.8 shows the reduced 
(ascorbate) and oxidised (dehydro-L-ascorbate) forms of ascorbic acid. Ascorbate 
can act as a reducing agent, and it is this property which gives ascorbic acid its 
antioxidant properties (Halliwell and Gutteridge, 1999). For example, ascorbate is 
capable of donating a hydrogen atom to peroxyl radicals, thus forming non-radical 
species (Gregus and Klaassen, 1996).
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Fig. 1.8. Structures of ascorbic acid in its reduced and oxidised forms, as well as the products of 
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1.4.3 Enzymic Oxidant Protection
Numerous enzymes play key roles in the antioxidant defences of a species, often 
working together to ultimately detoxify a radical (see Halliwell and Gutteridge, 
1999). For example, superoxide dismutase (SOD) is an enzyme found in virtually all 
eukaryotic cells and in every instance, catalyses the dismutation of superoxide, a toxic 
reactive intermediate, as in the reaction below:
O2 + + 2H+ —> H2O2 + O2
SOD is present in man in several forms: copper-zinc-SOD (Cu,Zn-SOD) is found in 
mainly cellular cytosol; manganese-SOD (Mn-SOD) is located primarily in the 
mitochondria; and a third form is also found extra-cellularly, EC-SOD. Catalase 
(CAT) is another enzyme found in many organisms and is present in most major 
organs in man. The enzyme catalyses the breakdown of hydrogen peroxide, a toxic 
oxidant, into water and oxygen.
Glutathione peroxidase (GPX) utilises GSH as its substrate, in order to detoxify 
hydrogen peroxide, according to the below reaction:
H20 2 + 2GSH -> GSSG + 2H20
Together, these enzymes often act in concert to detoxify products of oxidative stress, 
as outlined in fig. 1.9.
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Fig. 1.9. Detoxification of the superoxide anion radical (02* ) by superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPX) (source: Gregus and Klaassen, 1996).
2GSH GSSG
2HOHGPX
SOD HOOH — <0*
CAT 2HOH2H+
HOOH
In combination, each component of an antioxidant defence system produces an 
effective mechanism to protect that organism. However, in certain circumstances 
detoxification fails and damage ensues. Detoxification may fail, for example, when 
depletion of antioxidants such as glutathione or vitamin E occurs. Similarly, if excess 
toxins accumulate in the organism, protective enzymes may become saturated and 
their sources of cofactors, necessary for normal functioning, exhausted.
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1.4.4 Antioxidants in Seminal Fluid
Seminal fluid contains several antioxidants commonly found in blood plasma, albeit 
in many cases, at differing concentrations. Due to the importance of protecting sperm 
from radical attack, and thus maintaining fertility status and genetic integrity, many 
studies have investigated the antioxidant capacity of sperm and seminal plasma. 
Seminal plasma contains high levels of ascorbic acid (400 pmol/L) compared to 
blood plasma (40 pmol/L) (Fraga et al., 1991; Thiele et al., 1995; Lewis et al., 1997), 
which would suggest that ascorbate has an important physiological role in the male 
reproductive tract. Indeed, ascorbate has been shown to be negatively correlated with 
sperm oxidative DNA damage (Fraga et al., 1991), seminal plasma and spermatozoal 
ROS production (Thiele et al., 1995; Lewis et al., 1997), and abnormal sperm 
morphology (Thiele et al., 1995).
Another important antioxidant that is a component of the diet in man is Vitamin E, 
comprising a group of four tocopherols. Vitamin E is a lipophilic compound, 
particularly efficient at protecting against lipid peroxidation through its reactions with 
alkoxy and lipid peroxy radicals, donating a hydrogen to them (Halliwell and 
Gutteridge, 1999). The vitamin E radical formed after such a reaction is not reactive 
enough to abstract a hydrogen from lipids, thus terminating the chain reaction of 
peroxidation. Seminal plasma is a rich source of vitamin E, which is not surprising in 
light of the particularly deleterious actions of lipid peroxidation on sperm, namely its 
associations with reduced fertility (Suleiman et al., 1996).
Uric acid is another antioxidant present in large amounts in seminal plasma, at 
concentrations of around 200 pM, similar levels to those found in blood plasma
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(Halliwell and Gutteridge, 1986; Lewis et al., 1997). Urate is a powerful scavenger 
of oxidants, again reflecting the importance of protecting sperm from the deleterious 
actions of radicals. Thiol containing compounds, including GSH, are also found in 
seminal plasma in large amounts, mainly associated with protein (Lewis et al., 1997). 
The protective enzymes CAT, SOD, GPX and GRD have also been detected in 
seminal plasma (Kobayashi et al., 1991; Sanocka et al., 1996; Alkan et al., 1997; 
Yeung et al., 1998). Additionally, CAT and SOD have been found at low levels in 
spermatozoa (Sanocka et al., 1997).
In addition to the high levels of antioxidants present in seminal plasma, spermatozoa 
themselves possess thiol groups, although substantially less than those found in 
seminal plasma, as well as less substantial amounts of ascorbic acid, vitamin E, uric 
acid and GSH (Li 1975; Lewis et al., 1997; Ochsendorf et al., 1998).
In conclusion, spermatozoa do not possess significant amounts of antioxidants. This 
produces a dependence of sperm on their extracellular environment for protection 




1.5 Cigarette Smoking and Reproduction
Cigarette smoking has escalated despite being one of the major risk factors to the 
general health of the public. By 1988, it was estimated that one billion people 
consumed an annual total of 5.2 trillion cigarettes world-wide (Connolly 1992). The 
consumption of cigarettes by men varies according to the region of the world, but is 
somewhere between 30 and 80 % (Council on Scientific Affairs 1990).
1.5.1 The Composition of Cigarette Smoke
Cigarette smoke and its condensates are comprised of many hundreds of potentially 
hazardous chemicals, including numerous free radical species (Halliwell and 
Gutteridge, 1999). Cigarette smoke itself contains over 4000 components, of which 
more than 50 are animal mutagens and carcinogens (Hoffmann and Hecht, 1989; 
Brunnemann and Hoffmann, 1992). The carcinogens can be divided into their 
respective classes; the major animal carcinogens being the nitrosamines, including 
tobacco-specific nitrosamines (TSNA) and volatile nitrosamines, polycyclic aromatic 
hydrocarbons (PAH) and heterocyclic and aromatic amines. These compounds are 
implicated in the genesis of several cancers in man, most commonly lung cancer, 
followed by cancer in the colon and rectum, but also cancers of the oral cavity, 
pancreas, kidney and urinary bladder, amongst others (Pitot and Dragan, 1996). 
Tobacco, obtained from the plant Nicotinia, contains around 40 individual alkaloids, 
the majority of which are 3-pyridyl alkaloids. Nicotine is the principal alkaloid in 
tobacco, comprising as much as 95 % of the total alkaloid content, and is a highly 
addictive compound in man.
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The alkaloids present in tobacco are either secondary or tertiary amines, which are 
capable of undergoing nitrosation. Fig. 1.10 shows a proposed mechanism for the 
formation of several TSNA through the enzymic metabolism of nicotine and other 
alkaloids present in tobacco smoke in vivo.
Fig. 1.10. Proposed mechanism for the production of tobacco-specific nitrosamines (TSNA) in vivo 
(source: Brunnemann etal., 1996).
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The rate of nitrosation is variable (Brunnemann et al., 1996). Generally, nitrosation is 
slow in vivo. However, the drying, curing and ageing of tobacco prior to human 
consumption can lead to the reduction of nitrate to nitrite and subsequent formation of 
TSNA following nitrosation. Ultimately, levels of nitrosamines in mainstream 
cigarette smoke vary according to the nicotine content and type of filter present on the 
cigarette; mainstream smoke being that which is inhaled during human consumption. 
High tar and nicotine cigarettes, containing around 12 mg tar and 1.9 mg nicotine, 
yielded 4-(methylnitrosamino-)-l-(3-pyridyl)-l-butanone (NNK) levels of 17 to 156 
ng/cigarette and N-nitrosonomicotine (NNN) levels of 49 to 287 ng/cigarette. Lower 
tar and nicotine containing cigarettes contain accordingly, significantly lower levels 
of nitrosamines.
PAH, formed by the combustion of carbonaceous materials, and aromatic and 
heterocyclic amines are present in both mainstream and sidestream tobacco smoke 
(Pitot and Dragan, 1996). These classes of compounds also represent several known 
or suspected mutagens and carcinogens in man (Pitot and Dragan, 1996).
Metabolism of the above compounds in vivo may result in the formation of reactive 
intermediates, that, potentially, are capable of damaging DNA and producing 
mutagenesis. This process is termed metabolic activation. Metabolic activation is 
invariably by one or more of the cytochrome P450 isofamily, prevalent throughout 
many tissues in the human body (Wrighton et al., 1996), including the testes 
(Parkinson 1996).
The TSNA are metabolically activated by hydroxylation, leading to the formation of 
several unstable and reactive intermediates (Parkinson 1996). Many intermediates
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are so unstable they spontaneously form other compounds which are capable of 
reacting with DNA. Upon reacting with DNA, methylation of a nucleotide often 
ensues, that may result in mutagenesis. Aromatic amines are activated by 
transformation to a reactive N-hydroxy intermediate, capable of producing other, 
more reactive species, that can produce DNA damage (Parkinson 1996). The toxicity 
of PAH is commonly through metabolism into toxic epoxides, which are capable of 
forming DNA adducts (Parkinson 1996). An example of the metabolic conversion of 
a polycyclic aromatic hydrocarbon, in this instant benzo[a]pyrene, by cytochrome 




Fig. 1.11. The metabolic conversion of benzo[a]pyrene to its mutagenic and carcinogenic diol- 
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Metals are also present in cigarette smoke that are also of toxicological interest, 
including cadmium, iron, arsenic, nickel, mercury, chromium, czs-platinum, beryllium 
and lead (Goyer 1996; Smith et al., 1997). Metals differ from other toxins in cigarette 
smoke previously discussed in that they are not created by tobacco combustion, but 
are present at residual levels in the soil and atmosphere where they may be absorbed 
by the tobacco plants. Several metals that are present in cigarette smoke have been
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smoke have been associated with mutagenesis and carcinogenesis in animals and/or 
man, including cadmium, lead, nickel, arsenic, chromium and beryllium (Goyer 1996; 
Smith et al., 1997).
1.5.2 Smoking and Male Reproductive Toxicology
Due to the mutagenicity of cigarette smoke, numerous studies have investigated the 
impact of male smoking on sperm, which have been reviewed several times (Mattison 
1982; Stillman et al., 1986; Little and Vainio 1994; Vine 1996). Smoking is
associated with an overall reduction in semen quality, specifically a reduction in 
sperm count and motility, and an increase in the number of abnormal cells (Pacifici et 
al., 1993; Vine et al., 1994; Sofikitis et al., 1995; Vine et al., 1996). Additionally, 
smoking has been associated with increased levels of aneuploidy in human sperm 
(Wyrobek et al., 1995), lower seminal plasma anti-oxidant levels, and increased 
oxidative damage to sperm DNA (Fraga et al., 1996; Shen et al., 1997).
Vine (1996) conducted a study analysing data from 27 separate reports that analysed 
male smoking and fertility. It was concluded that smokers showed a 13 % reduction 
in both sperm concentration and sperm motility compared to non-smokers, and a 
mean increase of 3 % in the number of abnormal sperm. Results of studies 
investigating semen quality and cigarette consumption are, however, not always in 
unison. For example, Vine et al. (1996) found a significant inverse correlation 
between sperm concentration and the number of cigarettes smoked per day and 
serum, semen and urine cotinine levels. Cotinine being a major metabolite of 
nicotine produce in vivo. However, Pacifici et al. (1993) found no such correlation
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between seminal nicotine and cotinine levels and cell concentration. Overall, it can 
be concluded that the majority of studies have found a negative association between 
sperm count, motility and morphology and cigarette smoking. It also appears that 
semen quality amongst smokers and non-smokers varies between healthy men and 
those with low fertility, with healthy men being more susceptible to the adverse 
effects of cigarette smoking (Vine 1996). The reason for this discrepancy is not 
known.
Several cancers of the reproductive system have been associated with male smoking 
by epidemiological studies. A direct action on the male is apparent, as prostate and 
testicular tumours are all more aggressive, if not more prevalent in smokers (Daling et 
al. 1992). In addition, an adverse effect on the partner of a male smoker has been 
reported; namely an increased risk of cervical cancer (Bosch et al., 1996).
There is also epidemiological evidence that pre-conceptual paternal smoking is 
associated with adverse effects on his offspring, as distinct from effects due to 
maternal and offspring passive smoking. Zhang et al. (1992) reported an overall 
elevated risk of birth defects in paternal smokers and concluded in their survey that 
paternal smoking may result in multiple rather than individual birth defects. Savitz et 
al. (1991) found certain abnormalities were positively associated with male smoking 
whilst others were negatively associated. Recent studies have also implicated pre- 
conceptual male smoking with enhanced risk of certain childhood cancers (Sorahan et 
al., 1995; 1997a; 1997b).
The toxic effects of metals that are present in cigarette smoke, industry and the 
environment on the male reproductive tract are also of concern (Thomas 1996). Lead
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exposure can result in infertility, sterility and increased levels of sperm 
morphological defects. Cadmium, iron, mercury, silver, cobalt, cw-platinum and 
molybdenum can adversely affect accessory gland function and spermatogenesis. In 
addition, deficiencies in the levels of essential metals, such as zinc and selenium, is 
associated with a reduction in sperm count and motility.
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1.6 Aims and Scope of the Project
It has been reported that male fertility has decreased by thirty percent over the last 
fifty years (Carlsen et al., 1992). However, the causative factors that could account 
for such a decrease are not yet well established. In addition, the quality of semen is 
increasingly under threat and factors that increase the incidence of sperm mutations 
and production of germline abnormalities which can result in birth defects and genetic 
disease in offspring, are an important area of study in order to protect human 
populations.
The aims of the study were to compare semen from smokers and non-smokers, in 
order to determine whether cellular differences exist between the two groups. In 
particular, the extent of DNA damage in the cells will be investigated, since that may 
predispose offspring to an increased risk of genetic anomalies. The production of 
mutations in sperm, according to the generation of aneuploidy, will also be 
ascertained. Additionally, potential associations between smoking and reduced 
fertility will be investigated.
Antioxidants in both seminal plasma and the spermatozoa themselves play an integral 
role in the protection of sperm and maintenance of male fertility. Cigarette smoking 
is known to produce oxidative stress and reduce the abundance of antioxidants in 
blood plasma (Halliwell and Gutteridge, 1999). Antioxidant levels will, therefore, be 
determined in the seminal fluid of smokers and non-smokers so as to determine 
whether smoking produces lower antioxidant capacity and increased levels of 
oxidative stress in semen, that may correlate with cellular damage and reduced 
fertility.
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The epididymis acts as a site for the storage and maturation of sperm. The 
antioxidant activity of the epididymal fluid will be determined, as well as the ability 
of the epididymis to support spermatozoal subsistence, by comparing the ejaculate of 
normozoospermic and vasectomized individuals.
Finally, an analytical assessment of seminal fluid will be performed in order to 
determine whether compounds are present that are capable of being beneficial to, or 
adversely affect, the male reproductive system and which could result in reduced 
fertility and/or offspring pathology.
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2. Sperm chromatin damage associated with male smoking
2.1 Introduction
Cigarette smoking is associated with several adverse effects on the male reproductive 
system, including a reduction in sperm count and motility and an increase in the 
number of abnormal cells (Pacifici et al., 1993; Sofikitis et al., 1995; Vine et al., 
1994; Vine et al., 1996). Smoking has also been associated with oxidative damage to 
sperm DNA (Fraga et al., 1996; Shen et al., 1997), and higher levels of sperm 
aneuploidy (Wyrobek et al., 1995).
Certain epidemiological studies have also implied that paternal pre-conceptual 
smoking may be associated with adverse effects on offspring. Sorahan et al. (1995; 
1997a; 1997b) found paternal pre-conceptual daily cigarette consumption produced 
an overall increase in all childhood cancers. Zhang et al. (1992) also reported an 
overall elevated risk of birth defects in offspring of paternal smokers. The 
measurement of DNA damage in spermatozoa is therefore critical in order to evaluate 
the potentially adverse effects of exposure to toxins, such as those found in cigarette 
smoke.
Several methods are available that enable the measurement of spermatozoal DNA 
damage.
2.1.1 Alkaline Single Cell Gel Electrophoresis Assay
The alkaline single cell gel electrophoresis, or ‘comet’, assay, is a sensitive visual 
technique that allows the measurement of DNA single and double strand breaks
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(Singh et al., 1989; McKelvey-Martin et al., 1993), and it has been applied to the 
determination of DNA damage in human sperm (McKelvey-Martin et al., 1993; 
Hughes et al., 1997). Cells are lysed, embedded in agarose on a microscope slide and 
electrophoresed under alkali conditions to promote unwinding of DNA. Cells are 
then stained with a nucleic acid dye, such as ethidium bromide, and viewed under 
fluorescence microscopy. Cells that contain DNA strand breaks cause the release of 
DNA supercoiling and allow the migration of DNA from cells. This produces the 
appearance of a ‘comet’ in such cells; the longer the comet tail, the greater number of 
strand breaks present in the cell. Fluorescent microscopy and image analysis software 
enable the quantification of the amount of damage present in a cell. The assay can be 
used to quantify DNA damage and repair of DNA, and it can determine whether all 
the cells showed the same degree of damage in a sample or whether a heterogeneous 
response occurs.
2.1.2 Terminal Deoxynucleotidyl Transferase Assay
The terminal deoxynucleotidyl transferase assay (TdTA), sometimes referred to as the 
TUNEL (TdT-mediated X-dUTP nick end-labelling) assay, allows the measurement 
of DNA strand breaks, through the addition of the biotinylated nucleotide dUTP to 3’- 
OH ends of DNA, sites of DNA breakage, using the enzyme terminal 
deoxynucleotidyl transferase (TdT; Gorczyca et al., 1993). Fig. 2.1 outlines the 
reaction occurring using the TdTA and a broken strand of DNA. The biotinylated 
nucleotide is labelled with fluoresceinated avidin (FITC-avidin) and its emissions are
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then determined using either flow cytometry or fluorescence microscopy, in order to 
ascertain the proportion o f cells containing strand breaks.
Fig 2.1. Diagram depicting the terminal deoxynucleotidyl transferase assay (TdTA). DNA strand 
breaks are measured through addition of the biotinylated nucleotide dUTP to 3'-OH ends o f DNA,
sites of DNA breakage, using the enzyme terminal deoxynucleotidyl transferase (TdT). The 
biotinylated nucleotide is labelled with fluoresceinated avidin (FITC-avidin) and its emissions can then 
be determined using either flow cytometry or fluorescence microscopy, in order to ascertain the 
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2.1.3 Determination of 8-hydroxy-2'-deoxyguanosine
Measurement of 8-hydroxy-2'-deoxyguanosine, or 8-OHdG (fig. 2.2), one of around 
twenty major oxidative DNA damage products, has been conducted in human sperm 
(Fraga et al., 1991; Fraga et al., 1996; Shen et al., 1997). The lesion is produced 
through the oxidative attack of guanine.





Chapter 2: Sperm chromatin damage associated with male smoking
Levels of 8 -hydroxy-2' -deoxy guano sine have been estimated at a total of 5 x 105 
oxidative adducts per spermatozoon (Fraga et al., 1991).
2.1.4 Sperm Chromatin Structure Assay
The sperm chromatin structure assay (SCSA) measures the susceptibility of sperm 
cells to acid or heat induced denaturation in situ (Evenson and Jost, 1994; Sailer et al., 
1995). During human sperm maturation, nuclear histones are replaced by 
arginine/cysteine-rich protamines, followed by chromatin stabilisation through intra- 
and inter-protamine cross-linking via disulphide bridges in the epididymis (Bedford 
1979; Balhom 1989). This process produces a highly condensed sperm nucleus that 
is more resistant to DNA cleavage and denaturation and in situ enzymatic degradation 
than a somatic cell. The SCSA measures the production of single stranded DNA 
(ssDNA) after acid or heat treatment and staining of cells using the metachromatic 
stain acridine orange (Evenson and Jost, 1994; Sailer et al., 1995).
The SCSA has been correlated with exposure to several mutagenic compounds 
(Evenson and Jost, 1993; Evenson et al., 1993a, 1993b). The assay also shows strong 
correlations with DNA strand breaks in human and other mammalian spermatozoa, 
determined using the TdTA (Sailer et al., 1995; Aravindan et al., 1997) and alkaline 
single cell gel electrophoresis assay (Aravindan et al., 1997). In addition, the assay is 
an effective predictor of fertility (Evenson et al., 1999). The SCSA provides results 
of a lower variability within an individual than any other standard semen variable and 
it is an objective, technically sound, biologically stable, sensitive and feasible 
measure of semen quality (Evenson et al., 1991).
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The present study analysed the DNA of sperm obtained from smoking and non­
smoking subjects, with a normozoospermic semen profile, using the SCSA and TdTA 
assay The purpose of this report is to document that more damage is present in the 
nuclear material of sperm from smokers compared to that of non-smokers, in the form 
of increased susceptibility to in situ DNA denaturation and higher levels of DNA 
strand breaks.
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2.2 Methods
2.2.1 Semen Samples
Semen samples were obtained from patients being screened for fertility at the Royal 
United Hospital, Bath, UK. All samples were collected by masturbation after 3 days 
of abstinence. Following liquefaction at room temperature for 1 h, semen analysis 
was performed by staff of the Royal United Hospital (only those classified as 
normozoospermic as defined by the World Health Organisation (WHO 1992) were 
included in the study). Normozoospermic samples were defined as possessing > 20 x 
106 spermatozoa/ml, forward progressive motility > 50%, normal morphology > 30% 
and < 1 x 106 white blood cells/ml. Samples were then stored at -20°C prior to use. 
The smoking status of each donor was recorded and the samples used in the study 
characterised as either non-smokers or smokers of more than 10 cigarettes per day. 
This study had the approval of the Bath District Ethics Committee.
2.2.2 SCSA
The SCSA measures the ratio of single stranded DNA (ssDNA; red fluorescence at 
(630 nm) to double stranded DNA (dsDNA; green fluorescence at 515-530 nm) after 
acid treatment and staining of cells using the metachromatic stain acridine orange 
(Evenson and Jost, 1994; Sailer et al., 1995). The higher the ssDNA : dsDNA ratio, 
the greater the degree of denaturation and the more fragile the chromatin structure. 
The change in gradient of the main population of cells taken from the scatter plot 
before and after acid treatment was used as a measure of denaturation; as dsDNA
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converts to ssDNA, the slope decreases. The SCSA was performed on 10000 cells 
from each of 35 non-smokers and 35 smokers and analysed by flow cytometry.
Two hundred microlitre aliquots of sperm (1-2 x 106/ml) were admixed with 0.40 ml 
of 0.1 % Triton X-100, 0.15 M NaCl and 0.08 N HC1, pH 1.4. After 30 seconds, the 
pH in the cell suspension was raised and the cells were stained by adding 1.2 ml of 
acridine orange buffer containing 6 pg/ml acridine orange, 370 ml 0.1 M citric acid, 
630 ml 0.2 M Na2HP04, 1 mM disodium EDTA and 0.15 M NaCl, pH 6.0 (Evenson 
and Jost, 1994; Sailer et al., 1995). Cells were analysed by flow cytometry using a 
laser light excitation of 488 nm.
2.2.3 TdTA
Cells are permeabilised, fixed and subjected to exogenous TdT enzymes in the 
presence of biotinylated 16-dUTP. The nucleotide is added to the 3’-OH ends of 
DNA strand breaks by TdT and detected by FITC-avidin. The concentration of cobalt 
is important in determining the sensitivity of the assay (Tabor 1998); therefore, 
experiments were first carried out in order to determine the optimum amount of CoCl2 
present in the incubate that provides maximal sensitivity.
Semen was thawed at room temperature, diluted to 5 x 105 cells/sample and 
centrifuged at 2000 x g for 10 minutes. The pellet was resuspended in ice cold 
formaldehyde (1 % (v/v) in PBS, pH 7.4) and fixed for 15 min. After fixation, the 
cell solution was centrifuged at 2000 x g for 10 min, resuspended in 70 % ethanol and 
stored for 3 days at -20°C. Before elongation, the cells were rinsed in PBS, 
centrifuged at 2000 x g for 10 min and then resuspended in 50 pi of reaction buffer
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(Boehringer Mannheim UK, Lewes, East Sussex, UK) containing 0.2 M potassium 
cacodylate, 2.5 mM Tris-HCl (pH 6.6), 0.25 mg/ml bovine serum albumin, 5 units 
TdT and 0.5 nM biotin-16-dUTP. The amount of CoCl2 present in the incubate was 
from 0 to 10 mM. Samples were incubated for 30 min in the dark at 37°C, washed in 
PBS and resuspended in 100 pi of the fluoresceinated staining solution (0.15 M NaCl, 
0.015 M sodium citrate, 2.5 pg/ml FITC-avidin, 0.1 % Triton X-100 and 5 % (w/v) 
non-fat dry milk). After incubating for 30 min in the dark at room temperature, 
samples were washed and resuspended in 1 ml PBS. Cells were further stained with 
propidium iodide (5 pg/ml in PBS), and 10000 analysed by flow cytometry. Control 
cells for each sample were treated identically except for the omission of the TdT 
enzyme. TdTA results were analysed by subtracting cells staining positively for 
FITC on the TdT-control frequency histogram from the TdT-positive histogram, 
yielding the number of cells possessing DNA strand breaks.
The TdTA was then performed on semen specimens obtained from 35 smokers and 
35 non-smokers.
All materials were obtained from Sigma-Aldrich unless otherwise noted (Sigma- 
Aldrich Chemicals, Poole, Dorset, UK), with the exception of solvents, which were 
obtained from BDH (BDH Laboratory Supplies, Poole, Dorset, UK).
2.2.4 Flow Cytometric Measurements
Measurements were made using a Becton Dickinson FACS Vantage flow cytometer 
(Becton Dickinson, Franklin Lakes, New Jersey, USA) and Cell Quest software.
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Immediately after staining, cells were passed through the machine and recordings 
started after 2 min to allow equilibration.
2.2.5 Statistical Methods
The data obtained using the above assays were not normally distributed (Anderson- 
Darling test for normality). Therefore, the non-parametric Mann-Whitney U was 
used to examine differences between samples from smoking and non-smoking 
donors, where a probability value of P<0.05 was considered significant. The 
statistical analyses were carried out using Minitab 11.12 (Minitab Inc., Pennsylvania, 
USA).
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2.3 Results
2.3.1 SCSA
Fig. 2.3 depicts typical SCSA flow cytometric data from a non-smoker, before (fig. 
2.3a) and after (fig. 2.3b) acid induced denaturation. Fig. 2.4 shows typical SCSA 
data from a smoker, before (fig. 2.4a) and after (fig. 2.4b) acid treatment. The scatter 
plots were gated to eliminate cellular debris emissions from the data acquired and 
show emissions at 530 nm (dsDNA) versus 630 nm (ssDNA). Frequency histograms 
were then produced representing the ratio of emissions at 630 : 530 nm (ssDNA : 
dsDNA). Prior to acid induced denaturation, both non-smoker and smoker data 
groups possessed similar scatter plots. Correspondingly, the frequency histograms 
were not distinguishable, with both displaying a single peak depicting the haploid 
population of cells. Following the acid treatment, a proportion of DNA in the cells 
denatures. This is observable on the scatter plots as a shift downwards towards the 
ssDNA axis and on the corresponding frequency histogram as an increase in the 
ssDNA : dsDNA ratio. A greater movement towards the ssDNA axis occurred to the 
main population of cells from the smoker samples on the scatter plots and similarly, a 
larger shift along the ssDNA : dsDNA axis occurred on the frequency histogram, as 
compared to the non-smokers’ sample plots. The change in gradient of the main 
population of cells taken from the scatter plot before and after acid treatment was 
used as a measure of denaturation; as dsDNA converts to ssDNA, the slope decreases. 
In Table 2.1 it is demonstrated that the change in gradient is significantly greater for 
the sperm of smokers compared to non-smokers sperm (P<0.02; n=35). There was no
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significant difference between the ratio of ssDNA : dsDNA of non-smokers’ and 
smokers’ sperm pre-acid treatment.
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Fig. 2.3. Typical SCSA data from a non-smoker, before (a) and after (b) acid treatment. Panels on the 
left show scatter plots depicting the fluorescence emissions at 530 nm (dsDNA) versus 630 nm 
(ssDNA). The scatter plots were gated to remove artifactual emissions produced by cellular debris. 
Panels on the right show the corresponding frequency histograms depicting the fluorescence emission 
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Fig. 2.4. Characteristic SCSA data from a smoker, before (a) and after (b) acid induced denaturation.
(a) Before acid treatment.
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Table 2.1. Gradient of the main population of cells taken from the flow cytometric scatter plots, 
before and after acid induced denaturation. Values are mean gradients ± SD (n=35).
Group Pre-acid Post-acid
Non-smokers 52.0° ± 2.5 39.8° ± 6.7
Smokers 50.1° ±0.7 27.9° ± 3.7*
* Comparison of the degree of DNA denaturation between smokers’ and non- 
smokers’ sperm samples post-acid treatment (P<0.02; n=35).
2.3.2 TdTA
Fig. 2.5 displays TdTA flow cytometric scatter plots produced using sperm obtained 
from the same specimen, in the presence of various amounts of cobalt. The optimum 
concentration of CoCl2 in the incubate in order to provide maximal sensitivity was 
found to be 2.5 mM. Thus, when measuring strand breaks in sperm from smokers 
and non-smokers, the amount of CoCl2 used during the TdT incubation was 2.5 mM.
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Fig. 2.5. TdTA flow cytometric scatter plots using sperm obtained from the same sample, incubated in 
the presence of various amounts of cobalt. The scatter plots were gated to remove artifactual 
emissions produced by cellular debris. Panels on the right show frequency histograms generated by 
the corresponding FITC emissions. The marker (Ml )  on the frequency histograms depicts the 
percentage of cells staining positively for FITC. The incubate containing 2.5 mM CoCl2 produced 
maximal sensitivity for the measurement of DNA strand breaks.
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Fig. 2.6 shows typical human sperm TdTA data from a non-smoker incubated in the 
absence of TdT (TdTA-control; fig. 2.6a) and in the presence of TdT (TdTA-positive; 
fig. 2.6b). Fig. 2.7 depicts typical TdTA data from a smoker incubated in the absence 
of TdT (fig. 2.7a) and in the presence of TdT (fig. 2.7b). The scatter plots were again 
gated to eliminate cellular debris emissions from the data acquired and they represent 
propidium iodide versus FITC emissions. Frequency histograms were produced from 
the FITC emissions. The marker (Ml) on the frequency histograms depicts the 
percentage of cells staining positively for FITC. By subtracting the number of FITC 
labelled cells in the TdTA-control from the TdTA-positive, the number of cells 
possessing strand breaks were determined (table 2.2). There was no significant 
difference between the TdTA-control groups of smokers versus non-smokers. The 
amount of strand breaks measured in smokers’ sperm was found to be significantly 
higher compared to non-smokers’ sperm (P<0.05; n=35).
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Fig. 2.6. Typical TdTA data from a non-smoking donor, showing TdTA-control (a) and TdTA- 
positive data (b). Panels on the left show scatter plots depicting propidium iodide versus FITC 
fluorescence emissions. The scatter plots were gated to remove artifactual emissions produced by 
cellular debris. Panels on the right show frequency histograms generated by the corresponding FITC 
emissions. The marker (Ml )  on the frequency histograms depicts the percentage of cells staining 
positively for FITC. By subtracting the percentage of cells staining positively for FITC in the TdTA- 
control from those in the TdTA-positive, the percentage o f cells possessing strand breaks were 
determined.
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Table 2.2. Percentage of sperm cells staining positively for FITC, revealing the presence of DNA 
strand breaks, as determined by the TdTA. Values are mean percentages ± SD (n=35).
Group % cells staining % cells staining Difference (b-a)
FITC-positive in the FITC-positive in the
absence of TdT presence of TdT
enzyme (a) enzyme (b)
Non-smokers 7.59 ±2.12 19.57 ±2.08 11.98 ±3.68
Smokers 6.46 ± 2.65 25.78 ±4.56 19.32 ±7.68*
* Comparison of the percentage difference of DNA strand breaks in non-smokers’ 
versus smokers’ sperm (P<0.05; n=35).
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2.4 Discussion
Some epidemiological studies have suggested that paternal cigarette smoking may 
predispose offspring to an increased risk of birth defects and childhood cancers 
(Zhang et al., 1992; Sorahan et al., 1995; 1997a; 1997b). In this study, we collected 
evidence to suggest that smoking adversely affects sperm nuclear material, which 
could potentially produce sperm DNA mutations and lead to the above observations. 
Flow cytometry has evolved as a useful tool for determining the reproductive effects 
of exposure to environmental, occupational and therapeutic toxins. The instrument 
allows the rapid, sensitive, objective and multiparameter measurements of adverse 
reproductive interactions of chemicals and an assessment of the fertility potential of 
sperm (Spano and Evenson, 1993). Several determinants of sperm pathology are 
possible using flow cytometry. Such end points include DNA and RNA content, 
production of diploid sperm, altered nuclear morphology, sperm cell viability, 
mitochondrial function and sperm chromatin structure. In addition, precise 
recordings of spermatozoal DNA content allow the determination of the proportion of 
X- and Y-chromosome bearing cells and subsequent sorting of these subpopulations 
for gender pre-selection.
Results from this study demonstrate that sperm DNA from smokers is more sensitive 
to acid-induced denaturation and contains more strand breaks than that from non- 
smokers. The differences observed in this study, we suggest, are the result of 
oxidative stress on developing or mature sperm as a consequence of cigarette 
smoking. Fraga et al. (1996) found smokers’ seminal plasma to contain lower levels 
of anti-oxidants and 50 % higher levels of 8-hydroxy-2'-deoxyguanosine, an
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oxidative lesion of DNA, compared to that of non-smokers. The concept that paternal 
smoking caused mutations in sperm DNA potentially leading to offspring pathology 
was also supported in this study. Mature sperm have very little cellular repair 
mechanisms (Hughes et al., 1997), thus allowing oxidative DNA damage to 
accumulate before potential fertilisation. Additionally, Fraga et al. (1991) found that 
oxidative damage to sperm DNA was not necessarily associated with decreased cell 
motility or viability, meaning fertilisation could still be possible by a cell possessing 
damaged DNA.
Several tobacco related compounds have been found in smokers’ seminal fluid, 
including nicotine and some of its metabolites, cotinine and trans-3’-hydroxycotinine 
(Pacifici et al., 1993; Pichini et al., 1994), precursors of the mutagenic tobacco 
specific nitrosamines (Hoffmann et al., 1994). Various aromatic hydrocarbons have 
also been discovered in seminal fluid (Notarianni et al., 1996). Rivrud (1988) 
determined that seminal plasma possessed an enhancing effect on the mutagenicity of 
benzo[a]pyrene in the Ames test, although no difference was observed between 
smokers’ and non-smokers’ samples. Additionally, the mammalian gonad possesses 
significant mixed function oxidase activity and is capable of metabolising a range of 
chemicals (Parkinson 1996). Ultimately, this may result in the activation of a 
chemical and formation of a reactive species capable of damaging DNA and other 
cellular components, that may produce diminished fertility. It is, therefore, possible 
that seminal plasma contains chemicals capable of causing sperm DNA damage in 
situ, particularly so in smokers’ plasma.
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We have found evidence of greater sperm DNA damage in smokers compared to non- 
smokers, in the form of a compromised chromatin structure when exposed to mild 
acid stress and more DNA strand breaks. These changes may be responsible, at least 
in part, to the numerous associations between smoking and male reproduction, 
including reduced semen quality and increased offspring pathology.
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3. Smoking is associated with sperm aneuploidy
3.1 Introduction
Aneuploidy is defined as a deviation of chromosome number from an exact multiple 
of the haploid state (Hoffmann 1996). Cells lacking a chromosome are defined as 
being nullisomic, those with one chromosome are monosomic, and those with two 
chromosomes are disomic. Aneuploidy is one of the most serious human 
chromosomal abnormalities, with approximately 1 in 300 live births estimated to be 
aneuploid (Jacobs 1992). The actual levels of aneuploid conceptions, however, are 
believed to be as high as 1 in 5, supportive of the theory that the majority of 
aneuploid embryos spontaneously abort (Hook 1985; Obe and Anderson, 1987). 
Furthermore, an aneuploid individual that survives to parturition often encounters 
severe adverse health as a consequence, which may include physical and mental 
defects, as well as reduced longevity. The potential contribution of human lifestyles 
to the generation of aneuploidy is therefore an important area of study.
According to live birth and foetal analyses, the paternal contribution to the generation 
of aneuploidies varies, with proportions ranging from 100 % for XYY, 50 % for 
XXY, 7 % for XXX, and between 5 and 20 % for several autosomal trisomies (Bond 
and Chandley, 1983).
The levels of aneuploidy in sperm have been frequently investigated amongst 
different populations of men (Holmes and Martin, 1993; Spriggs et al., 1996; Robbins 
et al., 1997; Rubes et al., 1998). The occurrence of disomic sperm is around 0.05 to 
0.2 % for the autosomes, and up to 0.4 % for the sex chromosomes.
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3.1.1 Induction of Sperm Aneuploidy
Several studies have analysed the influence of social factors on the generation of 
sperm cell aneuploidy. Robbins and colleagues (1997) determined the potential 
contribution of caffeine, alcohol and smoking on sperm aneuploidy load in healthy 
men. Caffeine and alcohol consumption was significantly associated with increased 
frequencies of several aneuploidies, including both autosome and sex chromosome 
numerical abnormalities. Smoking was only weakly correlated with XX-18 
aneuploidy, although increasing donor age was more strongly associated with the 
same abnormality. Rubes et al. (1998) demonstrated a significant association 
between cigarette consumption and the incidence of sperm disomic for chromosome 
Y.
3.1.2 Lipid Peroxidation in Semen
The determination of lipid peroxidation in sperm and seminal plasma has been 
performed a number of times. Suleiman et al. (1996) demonstrated higher levels of 
lipid peroxidation in sperm amongst asthenospermic and oligoasthenospermic men, as 
compared to normozoopsermic individuals. A negative correlation was also observed 
in the same study between spermatozoal lipid peroxidation and motility. The amount 
of lipid peroxides present in spermatozoa has been found to correlate with seminal 
plasma antioxidant activity (Smith et al., 1996), suggesting that reduced antioxidant 
defences may participate in the aetiology of infertility.
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In the present study, we measured the percentage of sperm, obtained from smoking 
and non-smoking donors, that were aneuploid for chromosomes Y and 1 using 
fluorescence in situ hybridisation (FISH). In order to indicate whether sperm from 
smokers are exposed to greater levels of oxidative stress than those of non-smokers, 
which may result in cellular damage, lipid peroxidation was determined in both sperm 
and seminal plasma. In addition, the total antioxidant capacity of seminal plasma was 
ascertained. We report that YY1 aneuploidy is significantly higher in sperm obtained 
from smokers, and that the total antioxidant activity of seminal plasma is lower from 
that of smokers compared to non-smokers.
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3.2 Methods
3.2.1 Semen Samples
Semen samples were obtained from patients aged between 20-30 years being screened 
for fertility at the Royal United Hospital, Bath, UK. All samples were collected by 
masturbation after 3 days of abstinence. Following liquefaction at room temperature 
for 1 h, semen analysis was performed by staff of the Royal United Hospital (only 
those classified as normozoospermic as defined by the World Health Organization 
(WHO 1992) were included in the study; see section 2.2.1). All samples were stored 
at -20°C prior to use. The smoking status of each donor was recorded and the 
samples used in the study characterised as either non-smokers or smokers of more 
than 15 cigarettes per day.
3.2.2 Fluorescence in situ hybridisation
Sperm aneuploidy was determined using multicolour FISH (Holmes and Martin, 
1993) from semen samples donated by 20 non-smokers and 20 smokers. Aneuploidy 
was assessed on 10,000 cells per sample using fluorescence microscopy, by utilising 
DNA probes specific for chromosomes Y and 1. The Y chromosome DNA probe was 
labelled with fluorescein, whilst the chromosome 1 DNA probe was labelled with 
Texas Red, enabling distinction between the two probes emissions.
Electrostatically coated slides (BDH Laboratory Supplies, Poole, Dorset, UK) were 
first cleaned by immersing for 5 min each in acetone, concentrated hydrochloric acid : 
95 % v/v ethanol (1:1)  and running tap water. Slides were then stored in a coplin jar 
containing distilled water at 4°C until use.
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Frozen semen was thawed at room temperature. Sperm cells were purified and 
concentrated by centrifugation through 2 ml 50 % v/v Percoll in PBS at 2000 x g for 
40 min. The pellet was resuspended and washed three times in 1 ml wash buffer (10 
mM Tris-HCl, 10 mM NaCl, pH 8.0), before being resuspended in 100 pi wash 
buffer. Spermatozoal smears were prepared on a cleaned microscope slide by placing 
10 pi of the washed cell solution onto a slide and dragging the cells evenly over the 
slide using a coverslip. The slides were allowed to dry at room temperature for 1 h 
before being placed into a coplin jar containing 1 M Tris-HCl (pH 8.0) and 10 mM 
dithiothrietol and left at room temperature for 30 min. Slides were then removed 
from this solution and placed in 50 mM Tris-HCl (pH 8.0) and 10 mM 3,5- 
diiodosalicylic acid and left at room temperature for 2.5 h. Slides were rinsed with 2 
x SSC (0.03 M sodium citrate, 0.3 M sodium chloride, pH 7.0) and air dried. The 
cells were then fixed in 70 %, 80 % and 100 % v/v ethanol for 2 min each and air 
dried. Slides were stored in a desiccator at room temperature for up to 4 weeks prior 
to the hybridisation procedure.
The denaturation solution (70 % v/v formamide in 2 x SSC, pH 7.0) was pre-warmed 
to 72°C. Slides were pre-warmed on a heating block to 37°C and placed in the 
denaturation solution for 8 min, processing no more than four slides at a time. After 
denaturation, slides were transferred quickly to 70 %, 80 % and 100 % v/v cold (- 
20°C) ethanol for 2 min each and air dried.
The directly-labelled satellite DNA probe (Oncor, Inc., Gaithersburg, Maryland, 
USA) was pre-warmed to 37°C for 5 min and vortexed gently. Probes (3 pi each) 
were combined with 60pl hybridising solution (65% formamide in 2 x SSC; pH 7.0)
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in a microcentrifuge tube and vortexed gently to mix. The probe was then denatured 
by heating in a 72 ± 2°C water bath for 5 min and gently vortexed to collect the 
contents at the bottom of the tube. The probe was placed in a 2-8°C ice bath until 
hybridisation. Unused probe solution was stored at -20°C and re-denatured before re­
use. A 12 pi aliquot of probe solution was placed onto each slide and covered with a 
22 x 22 mm glass coverslip. The perimeter was sealed with a thick layer of glass 
coverslip sealant (Oncor, Inc., Gaithersburg, Maryland, USA) and slides were 
incubated at 37°C in the dark for 3 h in a pre-warmed humidified chamber.
A wash solution containing 0.5 x SSC, pH 7.0, was pre-warmed to 72 ± 2°C in a 
water bath. The glass coverslip sealant was removed with forceps from the 
microscope slides and the coverslip carefully lifted off the slide. Slides were then 
immersed in the wash solution for 5 min without agitation and transferred to a coplin 
jar containing 1 x phosphate buffered detergent (Oncor, Inc., Gaithersburg, Maryland, 
USA). Counterstain was prepared by mixing 300 pi 4’6-diamidino-2-phenylindole 
(DAPI; 0.05 pg/ml; Oncor, Inc., Gaithersburg, Maryland, USA) with 300 pi Antifade 
(Oncor, Inc., Gaithersburg, Maryland, USA). Slides were removed from the 
phosphate buffered detergent after 10 min and excess fluid blotted from the edge, 
without allowing the slide surface to dry. DAPI-Antifade solution (12 pi) was added 
to each slide and covered with a glass coverslip (22 x 22 mm) and excess fluid blotted 
by pressing lightly on the slide with a tissue. Slides were evaluated using an epi- 
fluorescence microscope fitted with the following filters to enable visualisation of the 
probe and counterstain emissions:
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• to view the counterstain (DAPI) signal, a 365 nm excitation and 480 nm 
emission filter was employed;
• to view the Texas red signal, a 540 nm excitation and 525 nm emission 
filter was employed;
• to view the fluorescein signal, a 490 nm excitation and 525 nm emission 
filter was employed.
3.2.3 Determination of Lipid Peroxidation
Lipid peroxidation was measured in both seminal plasma and spermatozoa by 
determining the production of thiobarbituric acid reactive species (TBARS; Buege 
and Aust, 1978). When heated, lipid peroxides decompose and produce 
malondialdehyde (MDA) as one of several products (Halliwell and Gutteridge, 1999). 
Thiobarbituric acid, or TBA, reacts with MDA to generate a coloured product that 
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Sperm were separated from the seminal plasma by centrifugation of semen (1.5 ml) 
for 10 min at 2000 x g. The resulting pellet was resuspended in PBS to a 
concentration of 10 x 106 cells/ml. To 1 ml of the cell suspension and 1 ml of 
seminal plasma was added 2 ml thiobarbituric acid reagent (0.375 % w/v 
thiobarbituric acid, 15 % w/v trichloroaectic acid and 0.25 N HC1). The solutions 
were then incubated at 100°C for 15 min. After cooling, the precipitate was removed 
by centrifugation at 1000 x g for 10 min and the absorbance of the supernatant read at 
535 nm against a blank containing all the reagents, replacing PBS for biological 
sample. The concentration of TBARS in the samples was calculated using the molar 
extinction coefficient of MDA-TBA adducts (1.54 x 105 M^cm'1).
3.2.4 Determination of Total Antioxidant Activity
The antioxidant activity of biological tissues is a complex interaction between many 
different mechanisms, that, in combination with one another, results in the total 
antioxidant capacity of that matrix. Due to the complexity of the antioxidant systems, 
researchers have sought to produce methods that enable the measurement of the total 
antioxidant capacity of a sample. A method developed recently has enabled the rapid 
and reproducible estimation of the total antioxidant capacity of biological samples 
that possess only a small volume (Miller and Rice-Evans, 1996). The total 
antioxidant activity is determined according to the ability of plasma antioxidants to 
scavenge the 2’2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
cation (ABTS+*), inhibiting its absorption at 734 nm (Rice-Evans and Miller, 1994;
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Miller and Rice-Evans, 1996). The formation and inhibition of ABTS+* is outlined in 
fig. 3.1.
Fig 3.1. A flow diagram outlining the method for the determination of the total antioxidant activity in 
seminal plasma, as described by Miller and Rice-Evans (1996).






absorption at 734 nm
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Metmyoglobin (MetMb) was purified prior to use. MetMb (400 pM in 10 ml PBS) 
was added to 10 ml potassium ferricyanide (0.0244 g in 100 ml PBS). The mixture 
was then applied to a 35 x 2.5 cm Sephadex G-15-120 column, pre-equilibrated with 
PBS, pH 7.4, and eluted with 100 ml PBS. Fractions (10 ml) were collected and the 
absorbance of each fraction read at 490, 560, 580 and 700 nm. The absorbance 
reading at 700 nm was subtracted from the readings at 490, 560 and 580 nm to correct 
for background absorbance. The relative proportions of MetMb were then calculated 
according to the equation described by Rice-Evans and Miller (1994):
[MetMb] = 146A 49o - 108A560 + 2.1A580
[FerrylMb] = -62A490 +242A560 - 123A580 
[Mb02] = 2.8A490 - 127A560 + 153A58q
Only fractions containing over 94 % MetMb were used in the assay. Purified MetMb 
was diluted with buffer to a concentration of 140 pM and stored at -20°C prior to use. 
Semen (0.5 ml) was centrifuged at 3,000 x g for 10 min. An 8.4 pi aliquot of the 
supernatant was added to a solution containing 2.5 pM metmyoglobin and 150 pM 
ABTS in phosphate buffered saline (PBS). In order to start the reaction, 375 pM 
hydrogen peroxide was added to the mixture, producing a final volume of 1 ml. The 
solution was immediately vortexed, placed in a 30°C incubator and a clock was 
started. After 165 s, the reaction mixture was transferred to a 1 cm cuvette and 
absorbance read at 734 nm. Calibrations were performed using the synthetic vitamin 
E analogue, Trolox, dissolved in PBS, in place of seminal plasma.
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All materials were obtained from Sigma-Aldrich unless otherwise noted (Sigma- 
Aldrich Chemicals, Poole, Dorset, UK), with the exception of solvents, which were 
obtained from BDH (BDH Laboratory Supplies, Poole, Dorset, UK).
3.2.5 Statistical Methods
The data obtained using the above assays were normally distributed (Anderson- 
Darling test for normality). Therefore, the students t test was used to examine 
differences between samples from smoking and non-smoking donors, where a 
probability value of P<0.05 was considered significant. The statistical analyses were 
carried out using Minitab 11.12 (Minitab Inc., Pennsylvania, USA).
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3.3 Results
3.3.1 Frequency of Aneuploidy
Smokers possessed significantly higher levels of sperm aneuploid for YY1 compared 
to non-smokers (0.13% and 0.08%, respectively; P<0.05), although no difference was 
seen in the frequency of sperm aneuploid for Yl-1 (0.09% and 0.11%, respectively; 
P>0.05; table 3.1). Typical results gained using the FISH procedure with human 
sperm is shown in fig. 3.2-3.3.
3.3.2 Measurement of Lipid Peroxidation
TBARS concentration was similar in both smokers’ and non-smokers’ seminal 
plasma (4.56 ± 0.34 and 5.24 ± 0.41 nmol/ml respectively; P>0.05) and spermatozoal 
fraction (0.53 ± 0.04 and 0.51 ± 0.08 nmol/ml respectively; P>0.05; table 3.1).
3.3.3 Measurement of Total Antioxidant Activity
The total antioxidant activity of seminal plasma from smokers was significantly lower 
than the activity determined in non-smokers’ plasma (615.45 ± 140.21 and 755.76 ±
110.02 pmol/L respectively, P<0.05; table 3.1).
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Fig. 3.2. Photomicrograph displaying sperm under fluorescence microscopy at x 600 magnification, 
processed using FISH. The panel displays sperm labelled with DNA probes for chromosome 1, with 
each cell displaying a single signal.
78
Chapter 3: Smoking is associated with sperm aneuploidy
Fig. 3.3. Photomicrograph displaying sperm under fluorescence microscopy at x 600 magnification, 
processed using FISH. The panel shows sperm labelled with the Y chromosome probe. The arrow 
depicts an aneuploid cell, in this instance, one which possesses two Y chromosomes.
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Table 3.1. Frequency of aneuploidy in human sperm obtained from smokers and non-smokers. The 
levels of TBARS, corresponding to lipid peroxidation, in sperm and seminal plasma, and the total 
antioxidant activity of seminal plasma from the two groups, is also displayed
Parameter measured Smoker Non-smoker
Frequency of YY1 0.13%* 0.08 %
Frequency of Yl-1 0.09 % 0.11 %
TBARS concentration 4.56 ± 0.34 nmol/ml 5.24 ± 0.41 nmol/ml
(seminal plasma)
TBARS concentration 0.53 ± 0.04 nmol/ml 0.51 ± 0.08 nmol/ml
(spermatozoal)
Total antioxidant activity 615.45 ± 140.21 pmol/L* 755.761110.02 pmol/L
* Indicates a significant difference between smokers’ and non-smokers’ samples 
(P<0.05; t test; n=20).
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3.4 Discussion
This study showed that sperm from donors who smoked possessed significantly more 
YY1 aneuploid sperm compared to sperm from non-smokers. Total antioxidant 
activity was significantly lower in smokers’ seminal plasma compared to that of non- 
smokers’, which may reflect greater oxidative stress in semen from smokers. No 
difference, however, in TBARS concentration was observed between smokers’ and 
non-smokers’ seminal plasma or spermatozoa.
Decreased total seminal plasma antioxidant activity, as demonstrated in the current 
study in smokers’ compared to non-smokers’ seminal plasma, would provide less 
resistance against reactive oxygen species which may in turn give rise to increased 
levels of cellular damage. Several studies have demonstrated an association between 
seminal plasma antioxidants and male fertility. Lewis et al. (1995) showed that 
asthenozoospermia ejaculates possessed lower seminal plasma total antioxidant 
activity compared to those from normozoospermic men. Men of proven fertility also 
show greater total antioxidant capacity compared to patients attending infertility 
treatment and of questionable fertility (Smith et al., 1996). In addition, DNA damage 
and lipid peroxidation are also associated with low seminal plasma antioxidant levels 
(Fraga et al. 1996; Suleiman et al., 1996). It may be of relevance that the decreased 
seminal plasma antioxidant capacity observed in smokers, might predispose this 
population to greater risk of cellular damage, that may result in reduced fertility and 
increased possibility of spermatozoal mutations.
Aneuploidy is a serious genetic abnormality; therefore, causative factors are of 
importance in order to protect human populations at risk. This study provided results
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to indicate an association of smoking with the incidence of sperm aneuploidy, 
specifically sperm aneuploid for YY1. However, no difference was seen in the 
frequency of sperm aneuploid for Yl-1.
The generation of aneuploid cells usually arises as a result of non-disjunction, that is 
the failure of homologous chromosomes to separate at the first meiotic division or of 
sister chromatids to do so at the second meiotic division or mitosis (Hoffmann 1996). 
As a result of nondisjunction, one pole of the spindle receives both homologues or 
chromatids while the other receives neither. This results in the production of one 
daughter cell with one chromosome too many and one daughter cell with one 
chromosome too few. Additionally, aneuploidy may arise due to replication of an 
extra chromosome, loss of a chromosome during meiosis, premature centromere 
division and/or improper pairing of homologous chromosomes in prophase I 
(Hoffmann 1996).
Numerous compounds have been found to induce aneuploidy in various test systems 
(see Hoffmann 1996). These include pesticides, solvents and pharmaceuticals, such 
as anticancer and antifimgal drugs. The cellular mechanisms by which agents cause 
aneuploidy are not clear, although aneugens are often compounds that affect multiple 
sites other than DNA (Oshimura and Barrett, 1986; Natarajan 1993; Spriggs et al., 
1996). Compounds that alter tubule polymerisation can cause aneuploidy. For 
example, taxol, which enhances tubule polymerisation, and colchicine, which 
prevents tubule polymerisation, can induce aneuploidy in some mammalian cells. 
Interference with the centrioles or centromeres by agents such as ethidium bromide or 
diazepam, can also induce aneuploidy. Agents which affect microtubule assembly,
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for instance, by interfering with microtubule-associated proteins or calmodulin, can 
also promote aneuploidy induction. Additionally, alkylating agents are a group of 
compounds that can promote the production of aneuploidy. Of the compounds 
present in tobacco smoke, cadmium and lead are suspected aneugens in vitro and in 
certain animal species in vivo (Bond and Chandley, 1983).
In conclusion, further work is required to determine if the occurrence of sperm 
aneuploidy in chromosomes other than those examined in this and other studies is 
associated with cigarette smoking, and whether it shows correlations with 
spermatozoal oxidative stress and/or antioxidant levels, that may indicate how 
aneuploidy is arising.
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4. Seminal plasma reduces exogenous oxidative damage to human 
sperm, determined by the measurement of DNA strand breaks and 
lipid peroxidation.
4.1 Introduction
Oxidative stress is believed to be an important mediator of damage to spermatozoa 
that has been associated with various indices of cellular injury (Aitken 1995). Lipid 
peroxidation and DNA fragmentation have been correlated with the exposure of 
sperm to ROS (Chen et al., 1997; Lopes et al., 1998). In addition, excessive ROS 
formation by spermatozoa has been associated with decreased motility, abnormal 
morphology and a lowered capacity for sperm-oocyte penetration (Mann et al., 1980; 
Aitken and Clarkson, 1987; Aitken et al., 1989; Aitken 1994).
The preparation of sperm, prior to storage in vitro and manipulation for artificial 
insemination techniques, is associated with the generation of ROS and cellular 
damage. For example, Twigg et al. (1998) demonstrated that centrifugation of sperm 
is associated with both ROS formation and the production of DNA strand breaks and 
cellular lipid peroxidation.
In order to counteract the toxic effects of ROS, seminal plasma contains an array of 
antioxidant mechanisms. Semen contains high levels of ascorbate, urate and thiol 
groups, as well as less substantial amounts of glutathione (GSH) and a-tocopherol (Li 
1975; Lewis et al., 1997; Ochsendorf et al., 1998). In addition, the antioxidant 
enzymes catalase, superoxide dismutase (SOD), glutathione peroxidase (GPX) and 
glutathione reductase (GRD) have all been found in seminal plasma (Sanocka et al.,
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1996; Alkan et al., 1997; Yeung et al., 1998). Spermatozoa themselves contain 
negligible levels of antioxidants (Mann et al., 1980; Alvarez et al., 1989), thus 
rendering the cells particularly reliant on their immediate environment for protection. 
The high levels of seminal plasma antioxidants indicate an important role in the 
preservation of spermatozoa. Lopes et al. (1998) demonstrated that addition of 
antioxidants significantly decreased the amount of spermatozoal DNA damage 
induced by ROS in vitro. SOD has also been found in vitro to prevent the loss of 
sperm motility and the induction of cellular lipid peroxidation after exposure of sperm 
to ROS (Kobayashi et al., 1991). Dietary ascorbic acid supplementation has been 
shown to produce a decrease in human sperm oxidative DNA damage (Fraga et al., 
1991). Oral a-tocopherol has been associated with an increase in cell motility and 
reduced levels of lipid peroxidation (Geva et al., 1996; Suleiman et al., 1996). 
Additionally, a-tocopherol has been correlated with an improvement in the 
fertilisation rate of men with low fertility during an in vitro fertilisation program 
(Geva et al., 1996).
Washing of sperm and subsequent removal of seminal plasma removes the potential 
protectant capacity provided by the plasma. This situation can be exacerbated if the 
cells are washed and resuspended in solutions contaminated with transition metals 
(Halliwell and Gutteridge, 1999). Thus, the choice of solution that is used for the 
storage of cells in vitro should be carefully considered in order to minimise the 
production of cellular damage.
This study assessed the capacity of human seminal plasma to protect sperm from 
oxidative stress. Sperm were exposed to exogenous ROS by incubating cells in a
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medium containing H20 2, FeS04 and ADP. Various amounts of seminal plasma were 
added to the incubations, and the formation of spermatozoal DNA strand breaks and 
lipid peroxidation determined. The purpose of this chapter is to report that seminal 
plasma reduces the generation of strand breaks and lipid peroxidation in human 
spermatozoa during exposure to exogenous oxidative stress.
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4.2 Methods
4.2.1 Semen Samples
Semen samples were obtained from patients who being screened for fertility at the 
Royal United Hospital, Bath, UK. Only specimens donated by non-smokers were 
used in the study. All samples were collected by masturbation after 3 days of 
abstinence. Following liquefaction at room temperature for 1 h, semen analysis was 
performed by staff of the Royal United Hospital (only those classified as 
normozoospermic as defined by the World Health Organization (WHO 1992) were 
included in the study; see section 2.2.1). Specimens were then centrifuged at 2000 x 
g for 10 min, and the supernatant comprising the seminal plasma was removed from 
the cell pellet and stored at -80°C prior to use. The pellet was rinsed twice in TNE 
buffer (0.15 M NaCl, 0.01 Tris-HCl and Na2EDTA, pH 7.4) before being resuspended 
in the same buffer and stored at -80°C prior to use. This study had the approval of the 
Bath District Ethics Committee.
4.2.2 Treatment of cells
Cells were treated with hydrogen peroxide using the method described by Chen et al. 
(1997). Sperm were thawed at room temperature, centrifuged at 2000 x g for 10 min 
and resuspended in 1 ml Biggers, Whitten and Whittingham medium (BWW; Biggers 
et al., 1971). From each specimen, six aliquots containing 10 x 106 cells were 
removed and placed into separate 1.5 ml vials. To five sets of cells was added 1.8 
mM ADP, 0.1 mM H20 2 and 2.7 mM FeS04, and either 0, 10, 20, 40 or 60 % v/v 
seminal plasma. The cells were incubated in the seminal plasma collected from each
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respective donor. The remaining set of cells was incubated in the absence of H20 2 
and seminal plasma, in order to allow the measurement of basal levels of strand 
breaks or lipid peroxidation for each sample following the incubation period. The 
volume in each vial was made up to 0.5 ml with BWW and the cells were then 
incubated at 37°C for 1 h. After the incubation, the cells were centrifuged at 2000 x g 
for 10 min, rinsed twice in PBS and finally resuspended in 1 ml PBS before the 
determination of TBARS or DNA strand breaks.
4.2.3 Determination of DNA Strand Breaks
The TdTA allowed the measurement of DNA strand breaks by addition of 
biotinylated 16-dUTP to 3'-OH ends of DNA, sites of DNA breakage (Gorczyca et al., 
1993; Sun et al., 1997), using the enzyme TdT. Incorporation of the nucleotide is 
detected using FITC-avidin and the FITC emissions then determined by fluorescence 
microscopy in order to ascertain the proportion of cells containing strand breaks.
The TdT assay was performed using a modified method described by Sun et al. 
(1997). Cells (5 x 105) were smeared onto a microscope slide and allowed to air dry. 
The cells were then fixed and permeabilised by submersing each slide in ice cold 
formaldehyde (1 % (v/v) in PBS, pH 7.4). After 15 min the cells were rinsed in PBS 
and placed into ice cold 70 % v/v ethanol for 1 h. The cells were then rinsed in PBS 
before elongation. A 50 pi aliquot of buffer containing 10 units TdT, 0.5 nmoles 
biotin 16-dUTP, 0.2 M potassium cacodylate, 2.5 mM Tris-HCl (pH 6.6), 2.5 mM 
CoCl2 and 0.25 mg/ml bovine serum albumin (Roche Molecular Biochemicals, East 
Sussex, UK) was placed onto each slide. The samples were incubated in a humidified
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chamber at 37°C for 60 min and then rinsed in PBS. The cells were then stained 
using 25 \x\ of a solution containing 0.15 M NaCl, 0.015 M sodium citrate, 2.5 p.g/ml 
FITC-avidin, 0.1 % Triton X-100 and 5 % w/v non-fat dry milk. After incubating for 
30 min in the dark at room temperature, samples were rinsed in PBS and the cells 
further stained with 5 pg/ml propidium iodide. Control cells for each slide were 
treated identically except for the omission of the TdT enzyme. A total of 1000 cells 
were scored per slide as either FITC-negative or -positive, yielding the proportion of 
cells possessing DNA strand breaks.
4.2.4 Determination of Lipid Peroxidation
Lipid peroxidation was measured by determining the production of TBARS, 
according to the method described by Buege and Aust (1978), as described in section 
3.2.3.
All materials were obtained from Sigma-Aldrich unless otherwise noted (Sigma- 
Aldrich Chemicals, Poole, Dorset, UK), with the exception of solvents, which were 
obtained from BDH (BDH Laboratory Supplies, Poole, Dorset, UK).
4.2.5 Statistical Methods
The data obtained using the above assays were not normally distributed (Anderson- 
Darling test for normality). Therefore, the non-parametric Mann-Whitney U test was 
used to examine differences between the data groups where a probability value of
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P<0.05 was considered significant. The statistical analyses were carried out using 
Minitab 11.12 (Minitab Inc., Pennsylvania, USA).
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4.3 Results
4.3.1 TdTA
Fig. 4.1 displays the generation of DNA strand breaks in human sperm after 
incubation with 0.1 mM H20 2, 1.8 mM ADP, and 2.7 mM FeS04, in the presence of 
various amounts of seminal plasma. The proportion of cells possessing strand breaks 
after incubation in the absence of seminal plasma and hydrogen peroxide in the 
promoter system was 3.96 ± 1.15 %, which is similar to previously reported levels of 
DNA fragmentation in human sperm determined using the same method (Lopes et al., 
1998). The addition of hydrogen peroxide to the system produced a 3-fold increase in 
the cells exhibiting strand breaks, to 12.26 ± 1.46 % (P<0.05). The addition of 
seminal plasma to the incubate produced a significant decrease in the generation of 
DNA strand breaks, when the amount of plasma present was 40 % v/v or greater 
(P<0.05).
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Fig. 4.1. Generation of DNA strand breaks by sperm after incubation with 1.8 mM ADP, 0.1 mM 
H20 2 and 2.7 mM FeS04 and either 0, 10, 20, 40 or 60 % v/v seminal plasma. The control bar 
represents sperm incubated in the absence of hydrogen peroxide and seminal plasma. Each bar 
displays the mean ± SEM results obtained from 6 samples. * Represents a significant difference in the 
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4.3.2 Lipid Peroxidation
Fig. 4.2 displays the production of TBARS by human sperm after incubation with 0.1 
mM H20 2, 1.8 mM ADP and 2.7 mM FeS04 in the presence of various amounts of 
seminal plasma. Levels of cellular TBARS in the absence of hydrogen peroxide and 
seminal plasma were determined to be 0.111 ±0.016 nmol after incubation of 10 x 
106 spermatozoa at 37°C for 1 h. The addition of hydrogen peroxide to the system 
produced a significant increase in the production of TBARS to 0.402 ± 0.041 nmol/10 
x 106 spermatozoa (P<0.05). In fig. 4.2, it can be seen that aliquots of seminal plasma 
added to the incubate produced a significant decrease in cellular lipid peroxidation at 
a concentration of 60 % (v/v; P<0.05). The amount of plasma present during the 
incubation was also significantly associated with a lower production of TBARS (r = 
0.86; P<0.05).
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Fig. 4.2. Production of thiobarbituric reactive substances (TBARS) by spermatozoa after incubation 
with 1.8 mM ADP, 0.1 mM H20 2 and 2.7 mM FeS04 and either 0, 10, 20, 40 or 60 % v/v seminal 
plasma. The control bar represents sperm incubated in the absence of hydrogen peroxide and seminal 
plasma. Each bar displays the mean ± SEM results obtained from 6 samples. * Represents a 
significant difference in the generation of TBARS from the cells treated with hydrogen peroxide in the 
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4.4 Discussion
The present study collected evidence to indicate that exposure of sperm to hydrogen 
peroxide in the presence of ferrous sulphate and ADP produces DNA strand breaks 
and lipid peroxidation. The addition of seminal plasma to the incubate significantly 
reduced the amount of oxidative damage produced in the cells.
The addition of hydrogen peroxide to many cell types generates DNA strand breaks in 
addition to increased levels of DNA base modification products (Halliwell and 
Gutteridge, 1999). However, H20 2 itself does not induce DNA damage. The 
majority of the damage in vivo is thought to be due to transition metal ion-catalysed
production of the highly reactive hydroxyl radical, OH*, by the Fenton reaction. An
2+
example of Fenton chemistry in biology is the reaction of Fe with H20 2, which 
proceeds according to the equation below:
Fe2+ + H20 2 —> intermediate complex(es) —» Fe(III) + OH* + OH’
In concordance with the Fenton reaction, the amount of DNA damage induced in 
spermatozoa by H20 2 increases as the concentration of iron is raised in the reaction 
media (Chen et al., 1997).
The generation of ROS is an essential prerequisite for the normal functioning of many 
cells; however, excessive formation can lead to cellular pathology (Halliwell and 
Gutteridge, 1999). Exposure of sperm to ROS is associated with decreased fertility 
and the formation of lipid peroxidation and DNA damage (Mann et al., 1980; Aitken 
and Clarkson, 1987; Aitken et al., 1989; Aitken 1994; Chen et al., 1997; Lopes et al.,
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1998). In addition, the production of lipid peroxidation in sperm due to oxidative 
stress has been associated with a loss of cell motility (Alvarez and Storey, 1989; 
Aitken and Fisher, 1994). Several studies have also demonstrated that high seminal 
plasma antioxidant activity correlates positively with semen quality and low levels of 
DNA damage and lipid peroxidation (Fraga et al., 1991; Kobayashi et al., 1991; 
Suleiman et al., 1996). The antioxidant capacity of sperm and the extracellular 
environment within which they live, therefore, would seem to be significant factors in 
determining the aetiology of male infertility and, potentially, the incidence of 
germline mutations through spermatozoal DNA damage.
Mature human spermatozoa do not possess significant DNA repair mechanisms 
(Chandley and Kofman-Alfaro, 1971; Hughes et al., 1997) and contain negligible 
levels of antioxidants (Alvarez and Storey, 1989; Aitken and Fisher, 1994). 
Oxidative DNA damage, consequently, has the potential to accumulate, increasing the 
possibility of mutagenesis during fertilisation. In addition, Fraga and colleagues 
(1991) demonstrated that oxidative damage to sperm DNA was not necessarily 
associated with decreased cell motility or viability, indicating fertilisation may still be 
possible by a cell that contains damaged DNA.
Reports have also suggested that paternal influences contribute more to congenital 
anomalies and heritable disease than maternal factors. This is thought to be due to the 
increased levels of cellular divisions that occur in male germ cell production 
compared to female gametogenesis and the lack of spermatozoal DNA repair 
mechanisms, resulting in an increased risk of sperm mutations (Chandley and 
Kofman-Alfaro, 1971; Crow 1993; Hughes et al., 1997). Factors, therefore, that
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afford the protection of spermatozoa from oxidative stress are of importance. We 
have found evidence to suggest that seminal plasma possesses the capacity to protect 
sperm from the deleterious actions of oxidative attack. Seminal plasma contains high 
levels of antioxidants (Li 1975; Sanocka et al., 1996; Alkan et al., 1997; Lewis et al., 
1997; Ochsendorf et al., 1998; Yeung et al., 1998); thus, we hypothesise that the 
protection of spermatozoa afforded by the plasma is as a consequence of its 
antioxidant properties.
The incubation of spermatozoa in the presence of hydrogen peroxide and a transition 
metal also generated cellular lipid peroxidation. Lipid peroxidation occurs when 
polyunsaturated lipids become damaged due to oxidative stress (Halliwell and 
Gutteridge, 1999). The sperm cell membrane contains high levels of polyunsaturated 
fatty acids that give the sperm considerable fluidity, necessary to allow the cell to fuse 
with the oocyte. This, however, renders the cell more susceptible to the generation of 
lipid peroxides. Lipid peroxidation in spermatozoa results in decreased membrane 
fluidity and a reduced capacity for successful fertilisation (Aitken 1995).
The data may be of significance in studies detecting spermatozoal damage in 
individuals and during in vitro fertilisation treatment. The preservation of sperm in 
seminal plasma during storage and cell preparation might allow for an improvement 
in semen quality used for artificial insemination and decrease the potential for 
oxidative DNA damage to arise, that may reduce germline mutations.
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5. Antioxidant capacity of the epididymis
5.1 Introduction
Reactive oxygen species (ROS) are believed to be important mediators of damage to 
spermatozoa that have been associated with decreased motility, abnormal morphology 
and a lowered capacity for sperm-oocyte penetration (Mann et al., 1980; Aitken and 
Fisher, 1994; Aitken 1995). In order to counteract the toxic effects of ROS, seminal 
plasma and sperm possess an array of antioxidant mechanisms. The antioxidant 
enzymes catalase, superoxide dismutase (SOD), glutathione peroxidase (GPX) and 
glutathione reductase (GRD) have all been detected in seminal plasma (Sanocka et al., 
1996; Alkan et al., 1997; Yeung et al., 1998). In addition, semen contains high levels 
of thiol groups, ascorbic and uric acid, as well as less substantial amounts of 
glutathione (GSH) and vitamin E (Li 1975; Lewis et al., 1997; Ochsendorf et al., 
1998). Spermatozoa themselves also possess levels of thiol groups, although 
substantially less than those found in seminal plasma, as well as smaller amounts of 
ascorbic acid, vitamin E, uric acid and GSH (Li 1975; Lewis et al., 1997; Ochsendorf 
et al., 1998).
5.1.1 The Human Epididymis
The human epididymis is a single coiled duct, measuring approximately 5 metres in 
length. Anatomically, the duct is arranged into three sections. From the distal to the 
proximal end of the epididymis, is the caput, the corpus and the cauda epididymides 
(Amann 1987). The final stages of sperm maturation occur in the first two segments
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of the duct; whereas, the terminal section acts as a storage site for sperm prior to 
ejaculation. The epididymis provides an optimal environment for sperm storage and 
maturation (Hinton et al., 1995). The capacity of the epididymis, however, to protect 
sperm from oxidative attack through the local actions of antioxidants during 
epididymal storage has not thus far been well studied.
5.1.2 Epididymal Antioxidants
Yeung et al. (1998) found similar levels of SOD, GPX, GRD and catalase-like 
enzyme activity in human seminal plasma taken from normozoospermic and 
vasectomized donors (with ductal occlusion and hence no epididymal contribution to 
the ejaculate). Although the epididymis has been found to synthesise and secrete 
significant amounts of extracellular SOD, similar levels were detected in the semen of 
men with an intact ductal system and in that of vasectomized men (Williams et al., 
1998). GSH has been located in rat, mouse and bull epididymal homogenates 
(Agrawal and Vanha-Perttula, 1988a; Agrawal and Vanha-Perttula, 1988b; Agrawal 
et al., 1989) The enzyme y-glutamyl transpeptidase, required for the regeneration of 
oxidised or conjugated GSH, has also been found within the rat epididymal lumen 
(Hinton et al., 1991).
The mRNA distribution of various antioxidants and protective enzymes have also 
been investigated in the male reproductive tract of several species. Cellular, 
phospholipid hydroperoxide and epididymal GPX mRNA have been detected in the 
epididymis (Zini and Schlegel, 1997a, b). Cytoplasmic Cu,Zn- and EC-SOD mRNA 
have been detected in epididymal epithelia (Nonogaki et al., 1992; Zini and Schlegel,
99
Chapter 5: Antioxidant capacity of the epididymis
1997a), as have low levels of catalase mRNA (Zini and Schlegel, 1996), and the gene 
expressing glutathione S-transferase (GST) (Hales et al.; 1980).
Although the epididymis is adapted for the storage of spermatozoa, in man, around 
one third of sperm found in the ejaculate emanate from extra-epididymal sites (Freund 
and Davis, 1969; Jouannet and David, 1978). The sperm accumulate through 
previous ejaculations or spontaneous leakage of sperm from the epididymis into the 
vas deferans (Jouannet and David, 1978), where they then survive at core body 
temperatures. Upon ejaculation, sperm present in the vas deferans mix with 
spermatozoa expelled from the epididymis. The length of time the cells remain in the 
vas deferans is significantly correlated with decreased cell motility, concentration and 
fertilising ability according to the zona-free hamster oocyte penetration assay 
(Jouannet and David, 1978; Lewis et al., 1984; Richardson et al., 1984).
Vasectomy is a widely used and effective method of sterilisation. The time to 
azoospermia is dependent on the removal of extra-epididymal sources of sperm from 
the reproductive tract, a period of usually 2-3 months (Freund and Davis, 1969; 
Marshall and Lyon, 1972; Cortes et al., 1997). Thus, ejaculates obtained from 
recently vasectomized men provide a useful model of the effects of extra-gonadal 
subsistence on sperm viability. This can assist in the understanding of epididymal 
function and provide information regarding detrimental effects to sperm surviving 
distal to the epididymis.
The aim of the present study was to assess the contribution of the human epididymis 
to seminal plasma antioxidant activity which may protect sperm from oxidative attack 
whilst stored , at this site, by comparing the semen of normozoospermic and
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vasectomized men. The total antioxidant activity was determined in the seminal 
plasma of both groups. In addition, concentrations of thiols, ascorbate and urate, 
individual antioxidants that are abundant in human semen, were measured. Indication 
of the levels of lipid peroxidation was also determined according to the amount of 
TBARS in seminal plasma.
In addition, the study aimed to determine whether structural changes occur in the 
chromatin of sperm stored in extra-epididymal sites that may adversely affect cell 
viability and fertilising ability, by examining sperm from vasectomized men. This 
was performed by staining cells with toluidine blue and recording their spectra, 
allowing the detection of deficient nuclear protamine disulphide crosslinking and 
reduced chromatin condensation (Andreetta et al., 1995). Furthermore, the SCSA 
(Evenson 1988), which has been correlated with exposure to several mutagenic 
compounds (Evenson et al., 1993a; Evenson et al., 1993b; Evenson and Jost, 1993) 
and fertility status (Evenson et al., 1980; Evenson et al., 1986; Sailer et al., 1995), 
was used to measure the susceptibility of sperm cells to acid denaturation.
The purpose of the study is to report that seminal plasma from vasectomized men 
contains less total antioxidant capacity, lower thiol group concentrations and higher 
levels of lipid peroxidation, compared to men with an intact ductal system. We also 
report that extra-epididymal sperm, obtained from patients after vasectomy, possess 
more chromatin and DNA abnormalities when compared to specimens produced by 
normozoospermic individuals.
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5.2 Materials
5.2.1 Semen Samples
Semen samples were obtained from patients being screened for fertility at the Royal 
United Hospital, Bath, UK. All samples were collected by masturbation after 3 days 
of abstinence. Following liquefaction at room temperature for 1 h, semen analysis 
was performed by staff of the Royal United Hospital (only those classified as 
normozoospermic as defined by the World Health Organization (WHO 1992) were 
included in the study; see section 2.2.1). Semen from subjects who had undergone 
vasectomy were obtained 10-12 days post-operatively from the Bath Clinic, Bath, 
UK. Specimens were assessed by staff of the Bath Clinic and included for use in the 
study if the samples were azoospermic and contained <1 x 106 leukocytes/ml. 
Samples were then stored at -20°C prior to use. This study had the approval of the 
Bath District Ethics Committee.
5.2.2 Toluidine Blue Staining of Cells
During human sperm cell development, somatic histones are replaced by 
arginine/cysteine-rich protamines, followed by chromatin stabilisation through intra- 
and inter-protamine crosslinking via disulphide bridges in the epididymis (Bedford, 
1979; Balhom, 1989; Ward, 1994). This produces a highly stable and condensed 
chromatin structure. The nucleic acid stain, toluidine blue, has been used as a 
predictor of semen quality and altered chromatin structure in human sperm (Barrera et 
al., 1993; Andreetta et al., 1995). Toluidine blue staining of spermatozoa produces 
mainly orthochromatic (pale blue) nuclei, whilst a small percentage of cells stain
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metachromatically (violet or violet-blue) due to deficient protamine disulphide 
crosslinking and chromatin condensation (Andreetta et al., 1995).
Toluidine blue staining was performed according to a modified method of Andreetta 
et al. (1995). The procedure was carried out using semen from 18 vasectomized men 
and 25 men with a normal WHO semen profile. After thawing semen at room 
temperature, smears were made on electrostatically coated glass microscope slides 
(BDH Laboratory Supplies, Poole, Dorset, UK). Smears were air dried at room 
temperature for 1 h, fixed in absolute methanol for 5 min and air dried again. 
Staining was performed using 0.2 mg/ml toluidine blue (BDH Laboratory Supplies, 
Poole, Dorset, UK) in distilled water (pH 5.5) for 2 min. Prior to use, the toluidine 
blue was extracted three times with the same volume of toluene and once with 
chloroform to remove hydrophobic contaminants (Stockert et al., 1990). After 
staining, slides were washed in distilled water for 5 sec and air dried. The whole 
absorption spectra for the smear was then recorded using a Philips PU8710 UV/VIS 
spectrophotometer and PU8710/01 Falcon-Scan software (Philips, Cambridge, UK) 
as described previously (Gutierrez-Gonzalvez and Stockert, 1985). The background 
absorption spectra of unstained cells was subtracted from the respective stained 
smear.
5.2.3 SCSA
Using flow cytometry, the SCSA measures the amount of native double stranded 
DNA (dsDNA; fluorescence at 515-530 nm) and denatured single stranded DNA 
(ssDNA; fluorescence at >630 nm) present in sperm before and after acid or heat
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induced denaturation, using the metachromatic stain acridine orange (Evenson 1988; 
Evenson and Jost, 1994). Cells that possess chromatin abnormalities are more 
susceptible to denaturation than cells with an intact chromatin structure, and thus 
consequently show higher fluorescence emissions at >630 nm. The SCSA was 
performed as described in section 2.2.2, using sperm obtained from 13 vasectomized 
donors and 11 donors possessing a normal WHO semen profile.
5.2.4 Determination of total antioxidant activity
Semen was centrifuged at 3000 x g for 10 min, and the supernatant comprising the 
seminal plasma was removed from the cell pellet. The total antioxidant activity was 
determined spectrophotometrically according to the ability of seminal plasma 
antioxidants to scavenge the 2,2’-azinobis(3-ethylbenzothiazoline 6-sulfonate) 
(ABTS) radical cation, ABTS+#, inhibiting its absorption at 734 nm, as described in 
chapter 3, section 3.2.4. In order to study whether the antioxidant capacity varied 
over a period of time, determinations of the total antioxidant activity in seminal 
plasma was carried out in samples donated every two weeks by the same individual 
over a period of eight weeks.
5.2.5 Determination of total thiol concentration
Total plasma thiol concentration was determined according to the method described 
by Hu (1994). Semen (1 ml) was centrifuged at 3000 x g for 10 min. A 200 pi 
aliquot of the supernatant was mixed with 600 pi 0.25 M Tris base containing 0.20 
mM Na2ETDA, pH 8.2, 40 pi 10 mM 2,2-dithiobisnitrobenzoic acid and 3.16 ml
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absolute methanol. The solution was vortex mixed, left to stand at room temperature 
for 20 min, and then centrifuged at 3000 x g for 10 min. The absorbance of the clear 
supernatant was measured at 412 nm and subtracted from a blank containing distilled 
water in place of plasma. Total thiol concentration was then calculated using a 
standard curve constructed using reduced glutathione (GSH) in distilled water in 
place of plasma.
5.2.6 Determination of TBARS concentration
Semen was centrifuged at 3000 x g for 10 min, and the supernatant comprising the 
seminal plasma removed from the cell pellet. Lipid peroxidation was then determined 
in the seminal plasma according to the concentration of TBARS in the seminal 
plasma, as described in chapter 3, section 3.2.3.
5.2.7 Determination of ascorbic acid and uric acid concentration
Total plasma ascorbic and uric acid concentrations were determined according to a 
modified method of Pappa-Louisi and Pascalidou (1998), using HPLC with UV 
detection. The liquid chromatography system consisted of a Jasco PU-980 pump, a 
Jasco 851-AS autosampler fitted with a 50 pi injection loop, a Hichrom 5 pm 150 x 
4.6 mm C l8 column (Hichrom Limited, Reading, UK) and a Jasco UV-975 detector 
set at 280 nm (Jasco UK, Great Dunmow, UK). The mobile phase consisted of 0.05 
M disodium hydrogen phosphate buffer containing 2 mM Na2EDTA and 5 mM 
cetyltrimethylammonium bromide, adjusted to pH 4.0 using orthophosphoric acid. 
The mobile phase was filtered through a 0.45 pm filter under vacuum and degassed
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using helium before use. All separations were carried out at ambient room 
temperature, using a flow rate of 0.8 ml/min.
Semen (1 ml) was centrifuged at 3000 x g for 10 min. A 300 pi aliquot of the 
supernatant was admixed with an equal volume of cold 10 % w/v metaphosphoric 
acid containing 2 mM Na2EDTA. A 10 pi aliquot of 3,4-dihydroxybenzylamine (5 
mg/ml) was added to the acidified plasma solution, which acted as an internal 
standard for the quantification of ascorbic acid. Unlike ascorbic acid, uric acid is 
stable in sample and standard solutions and was quantified using an external uric acid 
calibration. The mixture was vortexed and centrifuged at 3000 x g for 10 min at 4°C. 
A 100 pi aliquot of the supernatant was added to 50 pi 0.5 M Tris buffer containing 
10 mM dithiothreitol, pH 9.0, in order to reduce oxidised ascorbic acid (dehydro-L- 
ascorbic acid) to ascorbic acid. After 5 min at 25 °C, the reaction was quenched by 
the addition of 50 pi 0.2 M H2S04. The volume was made up to 0.5 ml with 0.05 M 
disodium hydrogen phosphate buffer containing 2 mM Na2EDTA, pH 4.0, and 
filtered through a disposable 0.2 pm filter into a capped vial. Prior to injection, the 
sample was stored on ice in the dark. An injection volume of 50 pi was used for the 
analyses. All standards were prepared in mobile phase without the addition of 
cetyltrimethylammonium bromide.
All materials were obtained from Sigma-Aldrich unless otherwise noted (Sigma- 
Aldrich Chemicals, Poole, Dorset, UK), with the exception of solvents, which were 
obtained from BDH (BDH Laboratory Supplies, Poole, Dorset, UK).
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5.2.8 Statistical analysis
An Anderson-Darling test for normality was carried out on each data group to be 
examined statistically. Depending on the outcome, either an unpaired t test or a 
Mann-Whitney U test was employed to test differences between samples from 
normozoospermic donors and from vasectomized donors. A P value of < 0.05 was 
considered statistically significant. All statistical analyses were carried out using 
Minitab 11.12 (Minitab Inc., PA, USA).
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5.3 Results
5.3.1 Profile o f Semen Obtainedfrom the Donors used in the Study
Table 5.1 shows the semen characteristics of the ejaculates used in the study. The 
data concurs with that reported previously (Lewis et al., 1984; Richardson et al., 
1984), in that vasectomy results in a reduction in sperm cell concentration and 
motility (P<0.05).
Table 5.1. Semen characteristics of normozoospermic and post-vasectomy ejaculates, obtained for use 












3.5 ± 1.1 23.2 ± 10.3* 18.2 ±5.3* 50.3 ± 12.4
Normozoospermic
(n=29)
3.3 ±0.9 97.1 ±38.9 63.2 ± 9.7 57.5 ± 10.3
* Represents a significant difference from the normozoospermic donors’ sperm (P<0.05; t test).
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5.3.2 Toluidine Blue Staining of Cells
A typical normalised absorption spectra for human sperm stained with toluidine blue 
obtained from a normozoospermic donor and from a donor post-vasectomy is shown 
in fig. 5.1. Normozoospermic sperm smears produced an absorption maxima at 585- 
600 nm, with a shoulder at 635-645 nm. Extra-epididymal sperm smears produced a 
shift in the absorption spectra compared to normozoospermic sperm spectra, with 
both absorption maxima and shoulder being at shorter wavelengths, 565-580 and 625- 
635 nm respectively. The spectra produced were quantified using the 
orthochromatic/metachromatic (OM) ratio, or the ratio of absorption at 640 nm/560 
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Fig. 5.1. Normalised absorption spectra of methanol fixed human sperm smears stained with the 
nucleic acid dye toluidine blue. Curve A represents typical spectra for a vasectomized patient and 
curve B for a normozoospermic donor. Vertical dotted lines indicate the absorption values at 560 and 
640 nm, which were used to calculate the orthochromatic/metachromatic ratio (OM ratio; 640/560 nm) 
for each sample.
100
480 520 560 600 640 680
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The mean ± SD absorption at 560 nm and 640 nm, and the OM ratio of sperm from 
25 normozoospermic donors and 18 vasectomized donors, are displayed in table 5.2. 
Normozoospermic donors’ sperm smears produced a significantly higher OM ratio 
when compared to extra-epididymal sperm smears (P<0.01; t test). The absorption 
spectra were less intense for the vasectomized group compared to the 
normozoospermic group due to lower cell concentrations. Hence, reduced absorption 
is observed at 560 nm and 640 nm. The wavelength absorption peaks found using 
spectral analysis of nucleic acid-dye complexes, however, have been shown to be 
independent of cell concentration (Gutierrez-Gonzalvez and Stockert, 1985).
Table 5.2. Toluidine blue staining characteristics of human sperm from normozoospermic donors and 
donors post-vasectomy, evaluated from their spectral recordings. The ortho-/metachromatic (OM)
ratio represents the ratio of absorption at 640 nm/560 nm. Values are mean ± SD.
Donor group Absorption at Absorption at OM ratio
560 nm 640 nm
Post-vasectomy 0.079 ± 0.039 0.054 ± 0.034 0.657 ±
(n=l 8) 0.151*
Normozoospermic 0.125 ±0.188 0.117 ±0.193 0.956 ±0.201
(n=25)
* Represents a significant difference from the normozoospermic donors’ sperm 
(P<0.01; t test).
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5.3.3 SCSA
Fig. 5.2 depicts typical SCSA flow cytometric scatter plots from a normozoospermic 
donor, before (Fig. 5.2a) and after (Fig. 5.2b) acid induced denaturation. Fig. 5.3 
shows typical SCSA scatter plots from a vasectomized donor, before (Fig. 5.3a) and 
after (Fig. 5.3b) acid treatment. The scatter plots were gated to eliminate cellular 
debris emissions from the data acquired and show emissions at 530 nm (ds or native 
DNA) versus 630 nm (ss or denatured DNA). Before acid induced denaturation, the 
scatter plots show a central cluster of cells, depicting the haploid population of sperm. 
Following the acid treatment, sperm that show increased sensitivity to acid 
denaturation move out of the main population of cells. The proportion of cells 
outside of the main population was defined by the triangular regions depicted on the 
scatter plots in fig. 5.2 and 5.3. Note that the position of the main cluster of cells 
from the normozoospermic donor changed little after acid treatment, indicating that 
the majority of the cells’ DNA was resistant to the acid treatment. In contrast, the 
vasectomized donors’ sperm produce a marked shift in the acridine orange 
fluorescence emissions after acid treatment towards the 630 nm axis. In table 5.3, it 
can be seen that, before acid treatment, significantly more sperm were positioned 
outside of the main population of cells from the samples acquired post vasectomy 
compared to the normozoospermic samples (8.00 ± 8.19 and 0.53 ± 0.54 % 
respectively; P<0.05; t test). Concurrently, after acid treatment, there was 
significantly more sperm outside of the main population of cells from the samples 
acquired post vasectomy compared to the normozoospermic samples (15.86 ± 10.72 
% and 9.35 ± 7.25 % respectively; P<0.05; t test).
112
Chapter 5: Antioxidant capacity o f  the epididymis
Fig. 5.2. Typical SCSA data from a normozoospermic donor, before (a) and after (b) acid treatment. 
Panels show scatter plots depicting the fluorescence emissions of 5000 cells at 530 nm (ds or native 
DNA) versus 630 nm (ss or denatured DNA), with each dot representing the emission from a single 
cell. The cells positioned outside of the main population of normal sperm were defined by the 
triangular regions depicted on the scatter plots. The plots were gated to remove artifactual emissions 
produced by cellular debris.
b
630 nm (ssDNA) 630 nm (ssDNA)
Fig. 5.3. Characteristic SCSA data from a donor after vasectomy, before (a) and after (b) acid induced 
denaturation.
630 nm (ssDNA) 630 nm (ssDNA)
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Table 5.3. SCSA data of human sperm obtained from normozoospermic and vasectomized donors. 
The data shows the percentage of sperm that are outside the main population of cells before and after 
acid treatment, determined by the scatter plots depicting acridine orange fluorescence emissions at 530 
nm (ds or native DNA) and 630 nm (ss or denatured DNA). Values are mean percentages ± SD.
Donor group Before acid After acid
Post-vasectomy 8.00 ±8.19%* 15.86 ±10.72%*
(n=13)
Normozoospermic 0.53 ± 0.54 % 9.35 ± 7.25 %
(n - ll)
* Represents a significant difference from the normozoospermic donors’ sperm 
(P<0.05; rtest).
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5.3.4 Measurement of total antioxidant capacity
The total antioxidant capacity of seminal plasma in normozoospermic samples ranged 
from 473.69 to 887.84 pmol/L, and it ranged from 316.84 to 825.83 pmol/L in 
samples acquired from men with ductal occlusion (table 5.4). The normozoospermic 
group possessed significantly higher total antioxidant activity than that obtained using 
plasma from vasectomized individuals (680.17 ± 103.94 pmol/L and 606.69 ± 104.86 
pmol/L respectively; P<0.02; t test). The total antioxidant capacity did not 
significantly vary in samples obtained from six normozoospermic and four 
vasectomized individuals every two weeks over a period of two months (fig. 5.4).
Fig. 5.4. Total antioxidant activity of seminal plasma, determined in the same six normozoospermic 
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5.3.5 Measurement of thiol concentration
Plasma thiol content ranged from 76.93 to 261.71 pmol/L in normozoospermic men 
and 59.91 to 227.68 pmol/L in vasectomized men (table 5.4). Thiol concentration 
was significantly higher in the plasma of normozoospermic men compared to that of 
vasectomized individuals (128.60 ±45.81 and 101.55 ± 40.09 pmol/L respectively; 
P<0.05; Mann-Whitney U test).
5.3.6 Measurement of TEARS concentration
Plasma levels of TBARS ranged from 2.71 to 9.11 nmol/ml in the normozoospermic 
group and 4.59 to 10.00 nmol/ml in the vasectomized group (table 5.4). The 
concentration of TBARS were significantly higher in the seminal plasma of samples 
obtained from vasectomized donors compared to normozoospermic donors (7.98 ± 
1.36 and 5.66 ± 1.38 nmol/ml respectively; P0.001; t test).
5.3.7 Measurement of ascorbic acid and uric acid concentration
Fig. 5.5 displays a typical chromatogram of a seminal plasma extract, performed as 
described under materials and methods. Under the conditions employed, all peaks of 
interest were well resolved from interfering peaks and eluted in less than 12 min. 
Total seminal plasma ascorbic acid content ranged from 214.81 to 523.40 pmol/L in 
all individuals (table 5.4). No significant difference in plasma ascorbic acid content 
was found between normozoospermic and vasectomized men (384.88 ± 122.23 and 
396.48 ± 87.20 pmol/L respectively; P>0.05; t test). Levels of uric acid in seminal 
plasma ranged from 119.73 to 312.02 pmol/L in all individuals (table 5.4). There was
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also no significant difference in uric acid content between the normozoospermic and 
post-vasectomy data groups (197.62 ± 66.73 and 189.51 ± 53.34 pmol/L respectively; 
P>0.05; t test).
Fig. 5.5. Typical chromatogram of a seminal plasma extract executed as described under materials 
and methods, to allow the measurement of ascorbic and uric acid. The mobile phase (pH 4.0) 
consisting of 0.05 M disodium hydrogen phosphate, 2 mM Na2EDTA and 5 mM 
cetyltrimethylammonium bromide, produced retention times o f 6.69 min for uric acid, 9.15 min for 
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Table 5.4. Concentrations of antioxidants and malondialdehyde in the seminal plasma of 
vasectomized and normozoospermic men. Values shown are mean ± SD.
Parameter measured Post-vasectomy donor (n) Normozoospermic donor 
(n)
Total antioxidant capacity 606.69 ± 104.86 (n=23)* 680.17 ± 103.94 (n=23)
(pmol/L)
Thiol groups 101.55 ± 40.09 (n=16)* 128.60 ±45.81 (n=16)
(pmol/L)
Ascorbic acid 396.48 ± 87.20 (n=l 8) 384.88 ± 122.23 (n=18)
(pmol/L)
Uric acid 189.51 ± 53.34 (n=18) 197.62 ± 66.73 (n=l 8)
(pmol/L)
TBARS 7.98 ± 1.36 (n=19)*** 5.66 ± 1.38 (n=21)
(nmol/ml)
* Represents a significant difference from the normozoospermic donors’ sperm
(*P<0.05; ***P<0.001).
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5.4 Discussion
This study investigated whether the human epididymis is a region-specific source of 
antioxidants that are measurable in the ejaculate by comparing the semen of 
normozoospermic and vasectomized men. Total antioxidant activity was measured, 
as were concentrations of the individual antioxidants, ascorbate, urate and thiol 
groups. Concentration of TBARS, breakdown products of lipid peroxidation, were 
also determined. Additionally, the study used the SCSA to detect the sensitivity of 
human extra-epididymal sperm DNA to acid induced denaturation. Also, toluidine 
blue staining of the DNA in such cells allowed the assessment of protamine 
disulphide crosslinking and chromatin condensation.
The study is the first, to our knowledge, to demonstrate that seminal plasma from men 
with an intact ductal system possesses higher total antioxidant capacity and greater 
thiol group concentrations, when compared with plasma from vasectomized 
individuals. Concentrations of lipid peroxidation were lower in the seminal plasma of 
normozoospermic men compared to specimens from post-vasectomy donors, which 
may be due in part, to the greater total antioxidant capacity that was demonstrated. 
Furthermore, the results indicate that sperm surviving extra-epididymally in the male 
reproductive tract, after vasectomy, possess chromatin abnormalities, namely reduced 
protamine disulphide crosslinking, deficient chromatin condensation, and increased 
susceptibility to acid-induced denaturation.
The generation of ROS is an essential prerequisite for the normal functioning of many 
cells; however, excessive formation can lead to cellular pathology. Over-exposure of 
sperm to ROS is associated with decreased motility, abnormal morphology and a
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lowered capacity for oocyte penetration. Several studies have also demonstrated that 
high levels of certain antioxidants correlate positively with semen quality (Fraga et 
al., 1991; Fraga et al., 1996; Kobayashi et al., 1991; Suleiman et al., 1996). The 
antioxidant capacity of sperm and the environs within which they live would seem, 
therefore, to be significant factors in determining the aetiology of male infertility. 
Ascorbate, urate and thiols are the major individual antioxidants present in human 
semen (Lewis et al., 1997), and were therefore selected for measurement in this study. 
Thiol content in normozoospermic semen was significantly higher than in samples 
obtained from vasectomized men, suggesting the accumulation of thiol containing 
compounds such as GSH in the epididymal lumen. Ascorbic acid is present in blood 
plasma at levels of around 40 pmol/L, considerably lower than the seminal plasma 
content found in this and other studies (Fraga et al., 1991; Thiele et al., 1995; Lewis 
et al., 1997), suggesting that ascorbate has an important physiological role in the male 
reproductive tract. Previously, ascorbate has been shown to be negatively correlated 
with sperm oxidative DNA damage (Fraga et al., 1991), seminal plasma and 
spermatozoal ROS production (Thiele et al., 1995; Lewis et al., 1997), and abnormal 
sperm morphology (Thiele et al., 1995). Uric acid is an important antioxidant in 
blood plasma, where it is found at concentrations of approximately 200 pmol/L 
(Halliwell and Gutteridge, 1986), comparable levels to those detected in seminal 
plasma in the current study. However, as with ascorbic acid, uric acid was present at 
similar levels in both normozoospermic and vasectomized men. Ascorbate and urate 
do not, therefore, appear to be key antioxidants in the epididymis.
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The total antioxidant capacity of seminal plasma, calculated in this study according to 
the ability of antioxidants to scavenge the radical cation, ABTS+*, was determined to
be 680.17 ± 103.94 pmol/L for the normozoospermic group. This figure is under half 
the total antioxidant capacity determined using the same method for adult human 
blood plasma (mean 1.46 ± 0.14 mM; Rice-Evans and Miller, 1994), but it was 
significantly higher activity than that found in the plasma of men with ductal 
occlusion. The antioxidant capacity of an individual did not change significantly 
when samples were collected from the same donor every two weeks over an eight 
week period. Thus, it would seem that, over short periods at least, the total seminal 
plasma antioxidant activity is reasonably stable.
Using the antioxidant data obtained from vasectomized and normozoospermic men, 
the antioxidant capacity of the epididymis can be estimated by taking into account the 
proportion of the ejaculation volume that is contributed by the epididymis. Jouannet 
and David (1978) estimate that the epididymis voids approximately 0.7 ml in the 
average ejaculate, or around seventeen percent. The difference in antioxidant 
capacity determined between individuals with an intact ductal system and 
vasectomized men in the present study is 73. 48 pmol/L (680.17 -  606.69 pmol/L). If 
we assume that the volume the epididymis contributes to the ejaculation is 0.7 ml, 
then an estimated antioxidant capacity of the epididymal fluid is 51.44 nmol.
The elevated levels of TBARS found in the seminal plasma of vasectomized 
individuals concur with the lower antioxidant capacity that was demonstrated in this 
group, in that reduced antioxidant levels would provide less protection against the 
deleterious effects of ROS, such as generation of lipid peroxidation. Overall, the data
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appears to indicate that certain antioxidants, such as thiol containing compounds but 
not urate and ascorbate, accumulate in the epididymal lumen, where they may then 
protect against the adverse effects of ROS.
Toluidine blue staining of spermatozoa demonstrated that when stored distal to the 
epididymis, the cells possess lower protamine disulphide crosslinking and reduced 
chromatin condensation compared to normozoospermic cells. These abnormalities 
have previously been correlated with reduced fertility of human sperm (Barrera et al., 
1993; Andreetta et al., 1995).
The SCSA produced considerable differences between the relatively homogeneous 
acridine orange staining pattern of normozoospermic cells and the heterogeneous 
staining pattern of sperm from vasectomized donors. Both before and after acid 
treatment, significantly more extra-epididymal sperm were situated outside of the 
main population of cells compared to normozoospermic sperm, indicating damaged 
chromatin and DNA structure. Increased sensitivity to acid induced denaturation in 
the SCSA has previously been shown to be predictive of high levels of chromosomal 
breaks (Estop et al., 1993) and DNA strand breaks (Sailer et al., 1995). The results 
also concur with the toluidine blue data, in that infertile specimens have been shown 
to be more sensitive to acid- or heat-denaturation in the SCSA as compared to 
normozoospermic samples (Evenson et al., 1980; Sailer et al., 1995). Thus, it appears 
that storage of sperm in the extra-epididymis produces nuclear changes similar to 
those already present in infertile sperm.
The mechanism by which sperm stored extra-epididymally develop an abnormal 
chromatin structure, as observed after vasectomy in this study, is unclear. Yanagida
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et al. (1991) demonstrated that sperm lost the ability to decondense and form 
pronuclei after exposure to heat at 60-120°C for between 20 and 120 minutes, and 
they concluded that mature, mammalian sperm were moderately resistant to heat 
treatment. Addition of the reducing agent, dithiothreitol, produced an increased 
sensitivity of the sperm nuclei to thermal treatment, suggesting that the resistance of 
the cells to heat was related to the disulfide crosslinking of sperm protamines. After 
heating sperm at 100°C for 5 minutes, Evenson and colleagues (1980) demonstrated 
that mammalian sperm chromatin was susceptible to in situ heat denaturation. 
However, both of these studies exposed sperm to temperatures well in excess of those 
found at core body temperatures in vivo, albeit for short periods of time, which 
questions whether storage of sperm at 37°C would result in chromatin changes due to 
thermal exposure.
The chromatin changes observed in the study may be explained by a reduction of 
nuclear protamine disulphide bridges. Perreault et al. (1984, 1988) demonstrated that 
oocyte glutathione levels correlate positively with sperm nuclear decondensation, 
indicating that higher levels of glutathione result in a greater reduction of protamine 
disulphide bonds. In addition, glutathione reductase has been positively correlated 
with male pronucleus formation (Lassalle and Testart, 1989). Both glutathione and 
glutathione reductase are present in the ejaculate of vasectomized men, demonstrating 
extra-epididymal sources of the substances. The potential for proteolytic degradation 
of sperm nuclear proteins extra-epididymally should also be considered. Protease 
treatment of sperm in vitro produces nuclear decondensation (Gall and Ohsumi, 
1976). The rate at which reduction of protamine disulphide bridges and proteolytic
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degradation occurs would be expected to be greater at the higher temperatures extra- 
epididymal sperm are exposed to, as compared to testicular temperatures. Indeed, 
Reyes et al. (1996) established that decondensation with heparin and glutathione was 
significantly faster at higher temperatures. As reported by Jouannet and David 
(1969), semen obtained post-vasectomy in this study did not contain higher numbers 
of white blood cells compared to normozoospermic seminal fluid; therefore, surgical 
trauma does not seem a likely candidate to explain the adverse effects observed in the 
cells chromatin.
Whether the changes observed in this study are relevant to the normal ageing process 
of sperm in non-vasectomized men cannot be discounted. As much as a third of 
sperm present in the normal ejaculate emanate from sites distal to the epididymis 
(Freund and Davis, 1969; Jouannet and David, 1978). The changes observed in the 
current study took place within two weeks of vasectomy; therefore, the accumulation 
of sperm in the vas deferans through previous ejaculations or spontaneous leakage 
from the epididymis and subsequent storage for a similar period of time might be 
expected to produce comparable chromatin changes.
Previous studies have also reported lower total antioxidant activity in the semen of 
infertile men compared to that from normozoospermic donors (Lewis et al., 1995; 
Smith et al., 1996), in addition to higher levels of lipid peroxidation (Sanocka et al., 
1996) and ROS (Alkan et al., 1997). The abundance of antioxidants and oxidative 
stress in the epididymis, therefore, may be an important determinant in male fertility.
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6. Analytical assessment of seminal plasma: associations with 
smoking and antioxidants
6.1 Introduction
Studies on semen quality collated from several reports indicate a reduction in sperm 
count and semen volume over the past fifty years (Carlsen et al., 1992). Various 
environmental factors have been postulated to contribute to such a decrease in male 
fertility, including exposure to oestrogen mimicking compounds, pharmaceutical 
drugs and social factors, such as cigarette smoking and alcohol consumption. The 
measurement of compounds in semen that may be detrimental to sperm, causing 
reduced fertility or genetic damage for example, is therefore, of importance.
6.1.1 Rate of Drug or Chemical Entry into Seminal Fluid
Generally, the passage of a compound from blood or plasma into semen occurs by 
passive diffusion, the rate at which is dependent on its physicochemical 
characteristics, such as molecular weight, lipid solubility, protein binding and 
dissociation constant (Pichini et al., 1996). The blood-testes barrier also acts as a 
specialised anatomic barrier to molecules. The rate of excretion of a compound into 
semen is determined predominantly by its dissociation constant, which in turn 
determines the concentration of undissociated compound, and the lipid solubility of 
the undissociated molecule. The ratio of a compound present in blood plasma 
compared to that of a biological matrix, such as semen, can be predicted using the 
Henderson-Hasselbach equation:
Chapter 6: Analytical assessment of seminal plasma: associations with smoking and antioxidants
CM _ 1 + 10(pHM-pKa) (for a weak acid)
CP 1 + lOCpHp-pKJ
CM _ 1 + 10(pKa -  p H ^  (for a weak base)
CP 1 + 10(pKa-p H P)
where:
CM and CP represent the total concentration of compound in biological matrix 
and plasma, respectively;
pKa is the negative logarithm of the acid dissociation constant for each drug; 
pHM and pHP are the negative logarithm of the hydrogen ion concentration in 
matrix and in plasma, respectively.
In accordance with the Henderson-Hasselbach equations, unbound molecules that are 
weak acids will concentrate in matrices whose pH is higher than that of plasma. The 
converse situation is true for weak bases. The matrix : plasma concentration will be 
near equal for compounds that are neither basic nor acidic.
6.1.2 Methods for the Extraction of Compounds from Seminal Fluid
Several methods exist for the extraction of compounds from many different matrices. 
One of the most common and simpler methods is liquid-liquid extraction. The 
partitioning of compounds into different solvents, allows the experimenter to 
selectively use a liquid that the compound(s) of interest will partition into, leaving in
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the remaining solvent as many interfering compounds as possible. Liquid-liquid 
extraction is relatively cheap, simple and effective. However, several drawbacks exist 
in the use of liquid-liquid extraction, such as an environmentally sound and 
economically viable method for the disposal of potentially large quantities of 
discarded solvents. The extracts produced are usually of a high volume and low 
concentration, often requiring long delays in analysis of the extract due to the 
necessity of concentrating the extraction solvent, which may result in the loss of 
volatile or unstable analytes. In addition, liquid extractions require extensive 
handling of samples which increases the potential for experimental error.
Solid phase extraction (SPE) is a technique based on the solubility and functional 
group interactions of an analyte, sorbent and solvent. In SPE, these interactions are 
utilised in order to isolate an analyte of interest on the sorbent and remove impurities 
and/or interferences with a suitable solvent. The analyte is then eluted from the 
sorbent using a small volume of solvent. When SPE columns are used optimally, a 
purified, concentrated solution of the analyte, free of compounds that would interfere 
with the qualitation and quantitation of the analyte, is produced.
An SPE procedure typically consists of four sequential steps, as depicted in fig. 6.1.
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Fig. 6.1 Typical steps that are to be carried out during solid phase extraction (SPE) (source: 


















1. SPE column conditioning
2. Application of the sample to the column
3. Washing o f the column to remove interferences
4. Elution o f the analyte from the column
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The majority of SPE procedures are now performed using disposable polypropylene 
columns, pre-packed with non-polar, polar or ion exchange sorbents. Common non­
polar sorbents are octadecyl (C l8), octyl (C8) and phenyl groups. The most 
commonly used polar sorbents are based on silica. Ion exchange sorbents can be 
either anion exchange, such as those containing amino groups, or cation exchange, for 
instance, those possessing carboxylic acid groups. The choice of sorbent is dependent 
on the analyte of interest and the matrix from which it is being removed. For 
example, a non-polar analyte can be extracted from a polar solution using a non-polar 
sorbent. After applying the solution to the SPE cartridge, the column can be washed 
with a polar solvent thus removing polar interferences from the sorbent, whilst 
retaining the analyte. The analyte can then be eluted using a small volume of a non­
polar solvent.
Supercritical fluid extraction (SFE) technology allows the efficient, rapid extraction 
of many compounds from various matrices. A supercritical fluid is a substance above 
its critical temperature and pressure. Fig. 6.1 displays the pressure-temperature phase 
of a pure substance, in which the regions correspond to solid, liquid and gas. If we 
move from the triple point (TP) to the supercritical point (CP), both pressure and 
temperature increase; the liquid becomes less dense due to thermal expansion and the 
gas becomes more dense as the pressure increases. At the critical point, CP, the 
densities of the two phases become identical and the distinction between the gas and 
liquid disappear. Above its critical temperature, the substance does not undergo a 
transition from liquid to gas or vice-versa. The substance in this region is said to be a 
supercritical fluid (Saito and Yamuchi, 1990).
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T e m p e r a t u r e
In order to be used in SFE, a fluid must possess solvating power. Table 6.1 shows the 
properties o f a gas, a liquid and a supercritical fluid. The diffusivity o f a supercritical 
fluid is greater than that o f a liquid by several hundred-fold. This results in faster 
mass transport compared to a liquid by the same factor. Viscosity is also a hundred 
times lower than a liquid, although the density is similar. The kinetic viscosity is 
defined as the viscosity divided by the density; thus the kinetic viscosity o f a 
supercritical fluid is very low compared with that of a liquid. As a consequence, the 
Reynolds number, defined as the inertial force divided by the viscous force, is 30 to 
100 times higher for a supercritical fluid than that o f a liquid for a given flow  
velocity. This increases turbulent flow in tubing and reduces the laminar flow
Super -  §§ 
C r i t i c a l ]
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dispersion. Overall, the mass transfer in an extraction employing a supercritical fluid 
solvent compared with a liquid solvent becomes much faster, offering a far higher 
throughput.
Table 6.1. Properties of a gas, a liquid and a supercritical fluid (source: Saito and Yamuchi, 1990).










A typical SFE system is comprised of a high-pressure pump(s), an extraction vessel 
that is contained within an oven and a back-pressure regulator, as shown in fig. 6.3.
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Fig. 6.3. A typical set-up for a SFE system. Note that the back-pressure regulator requires heating in 
















The back-pressure regulator ensures that the pressure of the entire system is 
maintained above the critical pressure of the fluid. Likewise, the extraction vessel is 
heated to ensure that the temperature of the solvent is above that of the critical 
temperature of the fluid.
The most commonly used substance as a supercritical fluid is carbon dioxide (Saito 
and Yamuchi, 1990). Carbon dioxide is relatively non-polar and can, therefore, be 
used for the extraction of many organic solutes. It is also relatively cheap and non­
toxic. Modifiers such as alcohols can be added to the supercritical fluid for the 
extraction of more polar compounds.
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6.2 Methods
6.2.1 Semen Samples
Semen samples were obtained from patients being screened for fertility at the Royal 
United Hospital, Bath, UK. All samples were collected by masturbation after 3 days 
of abstinence. Following liquefaction at room temperature for 1 h, semen analysis 
was performed by staff of the Royal United Hospital (only those classified as 
normozoospermic as defined by the World Health Organization (WHO 1992) were 
included in the study; see section 2.2.1). All samples were stored at -20°C prior to 
use. The smoking status of each donor was recorded and the samples used in the 
study characterised as either non-smokers or smokers of more than 5 cigarettes per 
day. This study had the approval of the Bath District Ethics Committee.
All materials were obtained from Sigma-Aldrich unless otherwise noted (Sigma- 
Aldrich Chemicals, Poole, Dorset, UK), with the exception of solvents, which were 
obtained from BDH (BDH Laboratory Supplies, Poole, Dorset, UK).
6.2.2 Statistical Methods
The data obtained using the above assays were not normally distributed (Anderson- 
Darling test for normality). Therefore, the non-parametric Mann-Whitney U test was 
used to examine differences between samples from smoking and non-smoking 
donors, where a probability value of P<0.05 was considered significant. The 
statistical analyses were carried out using Minitab 11.12 (Minitab Inc., Pennsylvania, 
USA).
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Section A: Detection of Compounds in Seminal Fluid using Supercritical Fluid 
Extraction Technology
A.6.1 Introduction
Several studies have indicated an adverse effect of smoking on the male reproductive 
system, including spermatozoal DNA damage (Fraga et al., 1996; Shen et al., 1997), 
increased levels of sperm aneuploidy (Wyrobek et al., 1995), and a reduction in sperm 
concentration and motility in the ejaculate (Pacifici et al., 1993; Sofikitis et al., 1995; 
Vine et al., 1994; Vine et al., 1996). Additionally, paternal cigarette smoking has 
been associated with certain childhood cancers and birth defects (Zhang et al., 1992; 
Sorahan et al., 1995; 1997a; 1997b). Furthermore, partners of male smokers are 
reportably at greater risk of developing cervical cancer (Bosch et al., 1996).
The purpose of the current study was to extract large volumes of seminal fluid so that 
identification of potentially toxic compounds could be performed from semen 
obtained from donors who smoked, and those that did not. Semen would be extracted 
using SFE, and the extracts would then be subjected to liquid-liquid extraction so as 
to aid in the resolution and identification of analytes, prior to GC-MS analysis. We 
report that several hydrocarbons were identified in seminal fluid. In addition, 
numerous cigarette smoke components and biological compounds were also 
positively identified.
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A.6.2 Methods
A.6.2.1 Extraction of Compounds in Seminal Fluid using SFE 
The extraction of organic compounds from seminal fluid was accomplished using a 
Jasco SFE system (Jasco UK, Great Dunmow, UK) using C02 as supercritical fluid at 
a flow rate of 3 ml/min and methanol as modifier at a flow rate of 0.3 ml/min. The 
entire system was maintained at a pressure of 200 kg/cm . An oven temperature of 
50°C was implemented.
Seminal fluid was thawed at room temperature and samples obtained from smokers 
and non-smokers each amalgamated separately to a volume of 30 ml. The plasma 
was deproteinated by admixing with 60 ml acetonitrile and the supernatant collected 
after centrifugation at 2000 x g for 10 min. The supernatant was mixed with 20 g a- 
cellulose and allowed to dry in a fume cupboard for 12 h at room temperature.
After drying, the packing material was placed into a 40 ml extraction vessel. The 
extraction vessel was topped up with a-cellulose and connected inside the SFE oven. 
The extraction vessel was then left inside the oven for 20 min at 50°C to allow 
temperature equilibration.
Once equilibrated, the C02 and modifier pumps were turned on and allowed to 
pressurise, whilst being isolated from the oven. Once pressurised, the extraction fluid 
was allowed to enter the oven and flow through the extraction vessel. The eluate was 
collected for 60 min in 1 ml acetone, that was stored on ice and protected from light. 
Once the extraction was completed, the acetone containing the extract was shaken 
with an equal volume of w-hexane. The mixture was centrifuged at 1000 x g for 10 
min and the «-hexane layer removed. This extraction was repeated and the w-hexane
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extracts combined. The acetone extract was then further extracted with two equal 
volumes of chloroform, as performed using «-hexane.
The acetone, w-hexane and chloroform extracts were dried using a rotary evaporator at 
room temperature, and the residue dissolved in 1 ml heptane. The heptane was then 
concentrated to a volume of 50 pi, prior to chromatographic analysis.
A.6.2.2 Chromatographic Analysis
The SFE extracts were analysed using gas chromatography combined with a mass 
spectrometer (GC-MS). GC-MS was carried out using a Hewlett Packard 5970 gas 
chromatographer (Hewlett Packard, Pennsylvania, USA) fitted with a 40 m BPX5 
column (SGE Chromatography, Milton Keynes, UK), and Hewlett Packard 5890 
mass spectrometer (Hewlett Packard, Pennsylvania, USA). Helium was used as the 
carrier gas, at a flow of 100 ml/min. A cold on-column splitless injector was used, 
whilst the detector and interface were held at 280°C. A 1.5 pi injection volume was 
used for each analysis. At the point of injection, the oven temperature was 60°C. 
Subsequently, the oven remained at 60°C for 2 min, before rising to 250°C at a rate of 
3°C per min. Data were acquired using Standard ChemStation software (Hewlett 
Packard, Pennsylvania, USA, 1996).
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A.6.3 Results
A.6.3.1 Extraction of Compounds in Seminal Fluid using SFE 
The initial SFE extract collected in acetone, was extracted sequentially with w-hexane 
followed by chloroform. The use of «-hexane allowed the extraction of non-polar 
hydrocarbons from the initial SFE extract. Chloroform allowed the removal of more 
polar compounds from the initial SFE extract. The use of liquid-liquid extraction 
enabled more precise determination of individual components in the chromatogram, 
due to the removal of many potential interfering compounds with each subsequent 
solvent extraction.
Each extract was injected into a GC-MS, which allowed a more precise identification 
of compounds through comparing their individual mass spectra with those stored in 
the ChemStation software database.
The ft-hexane extracts typically contained many long-chain hydrocarbons, identified 
according to their mass spectra (see fig. A.6.1-A.6.2). The aromatic hydrocarbon, 1,2 
benzenedicarboxylic acid, was also present in the w-hexane extract of both smokers 
and non-smokers semen.
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Fig. A.6.1. Typical chromatogram using gas chromatography with mass spectrometry detection of a 
30 ml seminal fluid extract, obtained from men who were cigarette smokers. The extract was collected 
in acetone and analysed as described under materials and methods, section A.6.2, using supercritical 
fluid extraction (SFE). The acetone fraction was then subsequently subjected to «-hexane and 
chloroform liquid-liquid extraction. This chromatogram represents the components contained in the n- 
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Fig. A.6.2. Several mass spectra obtained from a chromatogram using gas chromatography with mass 
spectrometry detection of a 30 ml seminal fluid extract. The extract was processed as described for 
fig. A.6.1. The mass spectra were produced from peaks contained in the «-hexane fraction.
Fig. A.6.2a. Mass spectra of eicosane, that was present in the semen of both smokers and non- 
smokers, produced after SFE o f 30 ml of semen. The uppermost spectra is that obtained from the 
samples chromatogram after GC-MS analysis, whilst the lower panel contains the spectra for eicosane 
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Fig. A.6.2b. Mass spectra of octadecanoic acid, that was present in the semen of both smokers and 
non-smokers, produced after SFE of 30 ml of semen. The uppermost spectra is that obtained from the 
samples chromatogram after GC-MS analysis, whilst the lower panel contains the spectra for 
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Fig. A.6.2c. Mass spectra of the aromatic hydrocarbon, 1,2 benzenedicarboxylic acid, that was present 
in the semen of both smokers and non-smokers, produced after SFE of 30 ml o f semen. The 
uppermost spectra is that obtained from the samples chromatogram after GC-MS analysis, whilst the 
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The chloroform extracts contained detectable quantities o f caffeine, as well as 
cholesterol, in both smokers and non-smokers semen (see fig. A.6.3-A.6.5). Nicotine 
and cotinine were also present in the seminal fluid obtained from smokers.
Fig. A.6.3. Typical chromatogram using gas chromatography with mass spectrometry detection of a 
30 ml seminal fluid extract, obtained from men who were cigarette smokers. The extract was collected 
in acetone and analysed as described under materials and methods, section A.6.2, using supercritical 
fluid extraction (SFE). The acetone fraction was then subsequently subjected to /i-hexane and 
chloroform liquid-liquid extraction. This chromatogram represents the components contained in the 
chloroform fraction. Compounds that were identifiable on the chromatogram according to their mass 
spectra are labelled.
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Fig. A.6.4. Typical chromatogram using gas chromatography with mass spectrometry detection of a 
30 ml seminal fluid extract, obtained from men who were not cigarette smokers. The extract was 
processed as described as for fig. A.6.3. Compounds that were identifiable on the chromatogram 
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Fig. A.6.5. Several mass spectra obtained from a chromatogram using gas chromatography with mass 
spectrometry detection o f a 30 ml seminal fluid extract, obtained from men who were cigarette 
smokers. The extract was processed as described as for fig. A.6.3. The mass spectra were produced 
from peaks contained in the chloroform fraction.
Fig. A.6.5a. Mass spectra o f nicotine, produced after SFE of 30 ml of semen obtained from men who 
smoked. The uppermost spectra is that obtained from the samples chromatogram after GC-MS 
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Fig. A.6.5b. Mass spectra o f cotinine, produced after SFE of 30 ml o f semen obtained from men who 
smoked. The uppermost spectra is that obtained from the samples chromatogram after GC-MS 
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Fig. A.6.5c. Mass spectra o f caffeine, produced after SFE of 30 ml of semen obtained from men who 
smoked. The uppermost spectra is that obtained from the samples chromatogram after GC-MS 
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Fig. A.6.5d. Mass spectra of cholesterol, produced after SFE o f 30 ml of semen obtained from men 
who smoked. The uppermost spectra is that obtained from the samples chromatogram after GC-MS 
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The components that remained in the acetone following w-hexane and chloroform 
extraction, did not contain any identifiable compounds. This was thought to be due to 
the polar nature of the extract. In order to improve the chromatography of the extract, 
the sample was derivatised with bis(trimethylsilyl)trifluoro-acetamide (BSTFA). 
Derivatisation was performed by first drying the sample under a stream of nitrogen, 
and resuspending the extract in 200 pi 50 % BSTFA in ethyl acetate. The solution 
was then heated for 2 hours at 100°C. The sample was again dried under a stream of 
nitrogen and resuspended in 50 pi heptane, prior to GC-MS analysis. This did not, 
however, improve the GC-MS analysis, and therefore, the results cannot be discussed.
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A.6.4 Discussion
This study utilised SFE technology and GC-MS in order to assess whether semen 
contains compounds that are capable of damaging the male reproductive system 
and/or producing toxic responses in the female reproductive tract upon exposure to 
semen. The results demonstrate the presence of caffeine in semen, as well as nicotine 
and cotinine in the semen of men who smoke. Several biological components were 
also positively identified in both smokers and non-smokers seminal fluid, including 
cholesterol, and several hydrocarbons such as eicosane and tetracosane. No 
difference in the number or amount of hydrocarbons were observed between semen 
from smokers and semen from non-smokers. The aromatic hydrocarbon, 1,2 
benzenedicarboxylic acid, was detected using GC-MS after the extraction of semen 
with SFE. Many aromatic compounds possess mutagenic and carcinogenic properties 
(Hoffman and Hecht, 1989; Brunnemann and Hoffman, 1992), and the toxic potential 
of this compound on the male and/or female reproductive tract cannot be discounted 
at this stage. However, 1,2 benzenedicarboxylic acid is used in the synthesis of 
plastics (Standard ChemStation software 1996). Therefore, the compound may be a 
component of the plastic containers that were used for the storage of semen, and not 
actually a normal resident of seminal fluid in vivo.
The confirmed presence of nicotine and cotinine cannot discount the possibility that 
nitrosamines may be present in semen, albeit at concentrations lower than those 
detectable using the current equipment. Testicular microsomes contain the hepatic 
biotransforming enzymes, the cytochrome P450 family (Parkinson 1996), thus 
activation of nicotine or cotinine to a mutagenic nitrosamine is plausible.
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Section B: Measurement of organic Compounds in Seminal Fluid using 
Supercritical Fluid Extraction: Associations with Cigarette Smoking
B.6.1 Introduction
The purpose of the current study was to develop a method based on SFE technology, 
that would enable an efficient and rapid extraction of organic compounds from 
seminal fluid. Specifically, we resolved to extract nicotine and one of its major 
metabolites in vivo, cotinine, as well as the commonly ingested food and drink 
component, caffeine, whose structures are shown in fig. B.6.1.
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We report a novel application of SFE for the extraction of several organic compounds 
from human seminal fluid, namely cotinine and caffeine. The method is rapid, 
reproducible and allows excellent recovery of analytes. However, nicotine was not 
adequately resolved in the chromatographic analysis to allow quantitation.
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B.6.2 Methods
B.6.2.1 Extraction of Organic Compounds in Seminal Fluid using SFE 
The extraction of organic compounds from seminal fluid was accomplished using 
SFE comprising C02 as supercritical fluid at a flow rate of 3 ml/min and methanol as 
modifier at a flow rate of 0.3 ml/min. The entire system was maintained at a pressure 
of 200 kg/cm , and an oven temperature of 50°C implemented.
To a 1 ml aliquot of seminal fluid was added 200 ng N-ethylnorcotinine in methanol 
to act as internal standard. The sample was deproteinated by admixing with an 2 ml 
acetonitrile and the supernatant collected after centrifugation at 2000 x g for 10 min. 
The supernatant was mixed with 1 g a-cellulose and allowed to dry in a fume 
cupboard for 2 h at room temperature.
After drying, the packing material was placed into a 10 ml extraction vessel. The 
extraction vessel was topped up with a-cellulose and connected inside the oven. The 
extraction vessel was then left inside the oven for 20 min at 50°C to allow 
temperature equilibration.
Once equilibrated, the C02 and modifier pumps were turned on and allowed to 
pressurise, whilst being isolated from the oven. Once pressurised, the extraction fluid 
was allowed to enter the oven and flow through the extraction vessel. The elute was 
collected for 30 min in 1 ml acetone, that was stored on ice and protected from light. 
The extract was dried under a gentle stream of nitrogen, and resuspended in 300 pi 
mobile phase prior to chromatographic analysis.
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B.6.2.2 Chromatographic Analysis
The SFE extracts were analysed using HPLC with UV detection. The liquid 
chromatography system consisted of a Jasco PU-980 pump (Jasco UK, Great 
Dunmow, UK), a Hichrom 5 pm 150 x 4.6 mm C l8 column equipped with a 
Hichrom guard column (5 pm, 10 x 4.6 mm; Hichrom Limited, Reading, UK), and a 
Jasco UV-975 detector set at 259 nm. The mobile phase consisted of 0.05 M sodium 
acetate containing water : acetonitrile (80 : 20 v/v), adjusted to pH 4.4 using acetic 
acid. The mobile phase was filtered through a 0.45 pm filter under vacuum and 
degassed using helium before use. A 50 pi injection volume was used for each 
extract. All separations were carried out at ambient room temperature using a flow 
rate of 1 ml/min.
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B.6.3 Results
B.6.3.1 Extraction o f  Organic Compounds in Seminal Fluid
With the use o f SFE technology, an excellent recovery o f caffeine and cotinine from 
seminal plasma was attained. Cotinine was recovered at a level o f 93.53 ± 2.29 %,  
and caffeine at 91.26 ± 2.84 %. Nicotine was poorly resolved by the chromatographic 
conditions employed and was not quantifiable.
Fig. B.6.2-B.6.3 displays the calibration curves produced following extraction of  
cotinine and caffeine from seminal fluid using SFE and HPLC analysis. The analysis 
was linear up to a concentration o f 500 ng/ml cotinine or caffeine (r = 0.997).
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Fig. B.6.3. Calibration curve for the analysis of caffeine from seminal fluid using SFE and HPLC
analysis.











Supercritical fluid extracts o f seminal fluid did not enable adequate chromatographic 
resolution o f nicotine (fig. B.6.4). Cotinine, however, was well resolved upon HPLC 
analysis. As cotinine is generally present at higher plasma concentrations than 
nicotine, is the major metabolite of nicotine produced in man, and provides a more 
accurate reflection o f cigarette consumption due to a longer plasma half-life, further 
steps to improve the resolution of nicotine to enable its quantitation were not 
undertaken.
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Fig. B.6.4. Typical chromatogram of seminal fluid obtained from a smoker, executed as described 
under materials and methods, section B.6.2, using supercritical fluid extraction and HPLC with UV 
detection, to allow the extraction and measurement of cotinine and caffeine. The mobile phase 
consisting of 0.05 M sodium acetate containing water : acetonitrile (80 : 20 v/v), pH 4.4, produced 
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B.6.4 Discussion
SFE was applied to the extraction of compounds from seminal fluid, allowing the 
subsequent HPLC determination of cotinine and caffeine. This application of SFE, 
allowed an efficient assay to be developed for these compounds. As the supercritical 
fluid, C02, forms a gas once it has left the pressurised SFE system, leaving behind a 
concentrated elute, the extraction is relatively rapid to perform bearing in mind the 
negligible concentrating of sample that is required prior to analysis.
Previous studies have determined nicotine, cotinine and caffeine levels in seminal 
plasma, utilising diatomaceous earth filled columns to extract the compounds 
followed by HPLC determination (Pacifici et al., 1993). However, when the same 
extraction was applied in the current study followed by HPLC analysis, poor recovery 
was produced (less than 10 %). In addition, the extracts were insufficiently clean to 
resolve the peaks of interest. These problems were resolved in the current study by 
the use of supercritical fluid technology.
Cigarette smoking has been associated with poor semen quality and spermatozoal 
damage, as discussed previously. The consumption of caffeine has also been 
correlated with spermatozoal aneuploidy (Robbins et al., 1997). Methods that enable 
the effective determination of such compounds in seminal fluid is, therefore, of 
importance. Future studies should determine thoroughly using a large number of 
samples and several different assays, whether, seminal levels of cotinine, caffeine and 
other potential reproductive toxins, show any correlations with poor semen quality 
and/or spermatozoal damage.
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Section C: Determination of Coenzyme Q10 in Seminal Fluid 
C.6.1 Introduction
Coenzymes Q, or ubiquinones, represent a group of lipid soluble benzoquinones 
involved in the mitochondrial respiratory chain; specifically the oxidation of 
succinate or reduced nicotine adenine dinucleotide (Rauchova et al., 1995). The 
ubiquinone structure comprises a 2,3 -dimethoxy-5 -methylbenzoquinone nucleus with 
a variable length side-chain, containing one to twelve mono-unsaturated trans- 
isoprenoid units, as detailed in fig. C.6.1. Current nomenclature describes the 
compounds as coenzyme Qn, where n equals the number of isoprenoid units, or 
ubiquinone x, where x designates the total number of carbon atoms in the side-chain 
and is a multiple of five. For example, coenzyme Q10 (CoQ10), can otherwise be 
named ubiquinone 50, and contains ten isoprenoid units or fifty carbon atoms in its 
side-chain. Of the coenzyme Q family, only CoQ10 has been found in man (Okamoto 
et al., 1985; Battino et al., 1990).
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Fig. C.6.1. Basic structure o f the coenzymes Q. The compounds are based on a 2,3-dimethoxy-5- 
methylbenzoquinone nucleus with a side-chain containing one to twelve mono-unsaturated trans- 
isoprenoid units.
The cellular levels of CoQ10 determine the rate of respiration that occurs in 
mitochondria (Lenaz et al., 1985). The abundance of CoQ10 in tissues is dependent 
on both exogenous dietary intake and endogenous biosynthesis (Littarru et al., 1990). 
Diets deficient in CoQ10 produce a marked reduction in plasma levels of the 
compounds (Kishi et al., 1986). In addition, increased metabolic demand or 
destruction of lipids through oxidative damage may result in CoQ10 depletion, 
ultimately producing energy depletion (Littarru et al., 1990; Alieva et al., 1995). 
Spermatozoal motility is highly dependent on a rich source of energy (Lewin and 
Lavon, 1997); therefore, reduced levels of CoQ10 might be expected to produce a 
reduction in cellular motility. Indeed, studies have demonstrated a positive 
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(Mancini et al., 1994; Alieva et al., 1997). CoQ10 in seminal fluid has also been 
correlated with the sperm count in the ejaculate (Mancini et al., 1994; Alieva et al., 
1997). In addition, seminal fluid levels of CoQ10 are significantly lower in oligo-, 
terato- and asthenozoospermic men compared to normozoospermic individuals 
(Mancini et al., 1994; Alieva et al., 1997).
In addition to its redox function, CoQ10 possesses potent antioxidant capacity and has 
the capacity to protect sperm from the generation of lipid peroxidation (Rauchova et 
al., 1995; Alieva et al., 1997). Since peroxidative processes are associated with the 
aetiology of infertility (Halliwell 1988; Aitken 1995; Suleiman et al., 1996), CoQ10 
levels may be of further importance.
The antioxidant activity is lower in the seminal plasma of men who smoke compared 
to that of non-smokers (Fraga et al., 1996). As CoQ10 possesses strong antioxidant 
properties, levels of the compound may be lower in smokers. In addition, several 
reports have suggested that sperm from smokers possess a lower motility when 
compared to non-smokers (Pacifici et al., 1993; Vine et al., 1994; Sofikitis et al., 
1995; Vine et al., 1996). This may be as a consequence of low CoQ10 levels and thus 
inadequate energy provision for the cells and/or reduced antioxidant capacity and 
increased oxidative damage. The purpose of the current study was to determine 
whether the levels of CoQ10 were different in sperm and/or seminal plasma obtained 
from normozoospermic smokers and non-smokers. We report that spermatozoal 
levels of CoQ10 were significantly associated with cell concentration, motility and 
morphology. However, no difference in spermatozoal or plasma levels were observed 
between smokers and non-smokers.
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C.6.2 Methods
C.6.2.1 Extraction of Coenzyme QI0 in Seminal Fluid using Liquid-Liquid 
Extraction
Seminal fluid (1 ml) was centrifuged at 2000 x g for 10 min, to allow the separation 
of plasma from the spermatozoa. The supernatant comprising the seminal plasma or 
the cell pellet was resuspended in 1 ml sodium dodecyl sulphate (20 %, w/v in PBS), 
and 125 ng of CoQ9, a ubiquinone that does not exist in man, added in ethanol to act 
as internal standard. After addition of 3 ml methanol : 1-propanol (95 : 5, v/v), the 
solution was vortexed for 30 s, and 4 ml of w-hexane added and the solution re- 
vortexed for 60 s. The aqueous and organic layers were separated by centrifugation 
(1000 x g for 10 min), and the upper organic phase collected. The aqueous phase was 
extracted again using the same procedure and the organic phases combined. The 
organic phase was dried under a stream of nitrogen and dissolved in 300 pi of 
ethanol, before analysis by HPLC.
C.6.2.2 Extraction of Coenzyme Q10 in Seminal Fluid using Liquid-Liquid 
Extraction and Solid Phase Extraction Cartridges
Extraction of CoQ10 in seminal fluid using liquid-liquid extraction and SPE cartridges 
was performed as described by Grossi et al. (1992). Seminal fluid (1.5 ml) was 
centrifuged at 2000 x g for 10 min, and the plasma separated from the spermatozoa. 
Seminal plasma (1 ml) or sperm (50 x 106) were resuspended in 1 ml sodium dodecyl 
sulphate (20 %, w/v in PBS; SDS), and 125 ng CoQ9 in ethanol added to act as 
internal standard. After adding 3 ml of methanol : 1-propanol (95 : 5, v/v), the
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solution was vortexed for 30 s, and 4 ml of «-hexane then added and the solution re- 
vortexed for 60 s. The aqueous and organic layers were separated by centrifugation at 
1000 x g for 10 min, and the upper organic phase collected. The aqueous phase was 
extracted again using the same procedure and the organic phases combined. A 500 
mg silica solid phase extraction (SPE) cartridge was conditioned with 2 ml «-hexane, 
before addition of the «-hexane biological extract. The cartridge was washed with 2 
ml of w-hexane and dried under vacuum. Two 0.5 ml aliquots of methanol were then 
added to the cartridge and the eluent collected. The eluent was then purified on a C l8 
SPE cartridge, previously conditioned with 2 ml methanol and equilibrated with 2 ml 
water. After washing the cartridge with 1.5 ml methanol, the extracts were eluted 
with two 0.15 ml aliquots of 2-propanol, before analysis by HPLC.
C.6.2.3 Chromatographic Analysis
Cellular and plasma levels of CoQ10 were determined using HPLC with UV 
detection. The liquid chromatography system consisted of a Jasco PU-980 pump 
(Jasco UK, Great Dunmow, UK), a Hichrom 5 pm 150 x 4.6 mm C l8 column 
equipped with a Hichrom guard column (5 pm, 10 x 4.6 mm; Hichrom Limited, 
Reading, UK), and a Jasco UV-975 detector set at 275 nm. The mobile phase 
consisted of ethanol: methanol (60 : 40 v/v) that was filtered through a 0.45 pm filter 
under vacuum and degassed using helium before use. A 50 pi injection volume was 
used for each extract. All separations were carried out at ambient room temperature, 
using a flow rate of 1 ml/min.
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C.6.3 Results
C.6.3.1 Profile o f Semen Obtained from Smokers and Non-smokers used in the 
Study
Semen obtained from men who smoked for use in the study possessed significantly 
lower sperm cell concentrations and reduced motility when compared to semen from 
non-smokers (P < 0.05; table C.6.1).
Table C.6.1. Profile of semen obtained from smokers and non-smokers used in the determination of 












2.5 ± 1.1 71.13 ±31.03 66.93 ± 10.65* 57.73 ± 17.11
Non-smoker 
(n = 15)
2.7 ± 0.7 86.73 ± 30.48 75.87 ± 12.23 55.60 ± 16.08
* Represents a significant difference from the semen obtained from non-smokers (P < 0.05).
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C.6.3.2 Measurement o f Coenzyme Q10 in Seminal Fluid
Dissociation o f CoQ10 from lipids and proteins using sodium dodecyl sulphate and 
methanol, followed by liquid extraction using «-hexane, did not provide adequate 
chromatographic resolution o f CoQI0 or CoQ9, and therefore was unsatisfactory for 
use in the analysis (fig. C.6.2 - C.6.3).
Fig. C.6.2. Typical chromatogram of a spermatozoal extract executed as described under materials 
and methods, section C.6.2, using liquid-liquid extraction with «-hexane, to allow the measurement of 
coenzyme Q 10. The mobile phase consisting of ethanol : methanol (60 : 40, v/v), produced retention 
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Fig. C.6.3. Typical chromatogram of a seminal plasma extract executed as described under materials 
and methods, section C.6.2, using liquid-liquid extraction with n-hexane, to allow the measurement of 
coenzyme Q l0. The retention times of coenzyme Q 10 and coenzyme Q9 were the same as those of the 
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Seminal fluid «-hexane extracts followed by SPE concentration and clean-up steps 
produced a cleaner chromatogram when compared to liquid extraction alone, and 
produced adequate resolution of both CoQ9 and CoQ,0 (fig. C.6.5 - C.6.6). The 
inclusion o f the SPE steps after liquid extraction was therefore implemented for the 
subsequent analysis.
When SPE was implemented following liquid extraction, CoQ10 recovery was high 
(93.73 ± 2.72 % for seminal plasma and 89.26 ±2.18 % for spermatozoa). Fig. C.6.4 
displays the calibration curve produced following extraction o f CoQ10 from seminal 
plasma and sperm using H-hexane followed by SPE clean-up and concentration steps. 
The analysis was linear up to a concentration of 250 ng/ml CoQ10 (r = 0.992).
Fig. C.6.4. Calibration curve for the analysis of CoQ10, following /7-hexane liquid-liquid extraction 
and solid phase extraction cartridge clean-up and concentration steps.
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Fig. C.6.5. Typical chromatogram of a spermatozoal extract executed as described under materials 
and methods, section C.6.2, using liquid-liquid extraction with /7-hexane followed by concentration 
and clean-up using solid phase extraction (SPE) cartridges, to allow the measurement of coenzyme 
Q ,0. The employment of SPE cartridges after liquid extraction using /7-hexane resulted in a far cleaner 
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Fig. C.6.6. Typical chromatogram of a seminal plasma extract executed as described under materials 
and methods, section C.6.2, using liquid-liquid extraction with «-hexane followed by concentration 
and clean-up using solid phase extraction (SPE) cartridges, to allow the measurement of coenzyme 
Qi0. The employment of SPE cartridges after liquid extraction using «-hexane resulted in a far cleaner 
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The mean amount of CoQ10 in spermatozoa was found to be 0.54 ± 0.27 ng/106 
sperm, and in seminal plasma 27.65 ± 2.09 ng/ml. A positive correlation was 
observed between spermatozoal CoQ10 levels and cell number and motility in both 
smokers and non-smokers (fig. C.6.7, C.6.9; P<0.05). A positive correlation was also 
observed between CoQ10 levels and normal cell morphology in the non-smokers data 
group (fig. C.6.11; P<0.05). No correlation was observed between seminal plasma 
levels of CoQ10 and any semen parameter (P>0.05).
Levels of CoQ10 in both spermatozoa and seminal plasma did not differ between 
smokers and non-smokers (P>0.05, t test), as can be seen in table C.6.2.
Table C.6.2. Levels of CoQ10in the spermatozoa and seminal plasma of smokers and non-smokers.
Group CoQ10 in spermatozoa CoQ10 in seminal plasma
Non-smokers 0.59 ± 0.28 ng/10° sperm 27.24 ±2.11 ng/ml
Smokers 0.50 ± 0.24 ng/106 sperm 28.06 ± 2.05 ng/ml
No difference was observed in the amount of CoQ10 between smokers and non-smokers in either the 
spermatozoal or seminal plasma fraction (P>0.05).
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Fig. C.6.7. Correlation of C0 Q10 levels in spermatozoa with sperm count in normozoospermic donors, 
who were classified as non-smokers (fig. C.6.7a) or smokers (fig. C.6.7b). The lines indicate the trend 
produced by linear regression.
Fig. C.6.7a
Non-smoker data 










Sperm count (x 10 /ml)
Fig. C.6.7b
Smoker data 
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Fig. C.6.8. Correlation of C0 Q10 levels in seminal plasma with sperm count in normozoospermic 
donors, who were classified as non-smokers (fig. C.6.8a) or smokers (fig. C.6.8b). The lines indicate 
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Fig. C.6.9. Correlation of CoQ,0 levels in spermatozoa with sperm motility in normozoospermic 
donors, who were classified as non-smokers (fig. C.6.9a) or smokers (fig. C.6.9b). The lines indicate 
the trend produced by linear regression.
Fig. C.6.9a
Non-smoker data
r = 0.809; P < 0.010.9
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Fig. C.6.10. Correlation of CoQ,0 levels in seminal plasma with sperm motility in normozoospermic 
donors, who were classified as non-smokers (fig. C.6.10a) or smokers (fig. C.6.10b). The lines 
indicate the trend produced by linear regression.
Fig. C.6.10a
Non-smoker data 
r = 0.148; P> 0.05
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Fig. C.6.10b
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Fig. C.6.11. Correlation of CoQ10 levels in spermatozoa with sperm morphology in normozoospermic 
donors, who were classified as non-smokers (fig. C.6.1 la) or smokers (fig. C.6.1 lb). The lines 
indicate the trend produced by linear regression.
Fig. C.6.1 la
Non-smoker data 








Sperm morphology (% normal forms)
Fig. C.6.1 lb
Smoker data 
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Fig. C.6.12. Correlation of CoQ,0 levels in seminal plasma with sperm morphology in 
normozoospermic donors, who were classified as non-smokers (fig. C.6.12a) or smokers (fig. 
C.6.12b). The lines indicate the trend produced by linear regression.
Fig. C.6.12a
32 Non-smoker data 
r = 0.250; P > 0.05
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C.6.4 Discussion
Cigarette smoking is associated with oxidative damage and reduced levels of 
antioxidants in semen (Fraga et al., 1996; Shen et al., 1997). In addition, smoking has 
been negatively correlated with spermatozoal motility (Pacifici et al., 1993; Sofikitis 
et al., 1995; Vine et al., 1996). This study indicates that CoQ10 levels are not 
significantly different in the seminal plasma or spermatozoa of smokers compared to 
non-smokers. Thus, the impaired motility that has been observed in sperm from 
smokers in several reports, including this study, does not appear to be as a 
consequence of reduced CoQ10 concentrations and subsequent lowered energy 
availability and/or reduced protection against oxidative attack. However, the 
significant correlations that were found between sperm count, motility and 
morphology and CoQ10 levels in spermatozoa, does indicate an important role of the 
compound in these parameters.
In conclusion, the cellular basis for the potential reduction of spermatozoal motility in 
cigarette smokers requires further consideration. Reduced levels of antioxidants, such 
as a-tocopherol, have been associated with a decrease in sperm cell motility (Geva et 
al., 1996; Suleiman et al., 1996). The lower antioxidant capacity demonstrated in 
smokers seminal plasma (Fraga et al., 1996; section 3.3.3) may account therefore for 
the lowered spermatozoal motility observed previously (Pacifici et al., 1993; Sofikitis 
et al., 1995; Vine et al., 1996).
176
Chapter 7: Conclusions and Future Work
7. Conclusions and Future Work
7.1 Summary of Results
The purpose of the present study was to determine whether smoking and/or depleted 
antioxidant levels causes spermatozoal damage, that may result in reduced fertility 
and offspring pathology. The study has determined that male cigarette smoking 
results in adverse effects on sperm. It was found that cigarette smoking produces 
damage to the chromatin of sperm. Specifically, greater susceptibility to acid-induced 
denaturation of DNA, increased levels of DNA strand breaks and higher frequency of 
YY1 aneuploidy was witnessed. Additionally, smoking was associated with lower 
seminal plasma total antioxidant activity. Smoking was not, however, associated with 
levels of spermatozoal or seminal plasma lipid peroxidation, according to the 
measurement of TBARS.
The protection afforded by antioxidants to spermatozoa was also investigated. 
Seminal plasma was found to reduce the formation of DNA strand breaks and lipid 
peroxidation after addition to an incubation media containing H20 2, FeS04 and ADP. 
The amount of seminal plasma present was also significantly negatively correlated 
with the formation of lipid peroxides. The epididymis provides optimum conditions 
for the storage and maturation of sperm (Hinton et al., 1995). The antioxidant 
capacity of the epididymal fluid, therefore, may be of importance in maintaining the 
integrity of spermatozoa whilst stored at this site. The epididymal antioxidant 
capacity was investigated by comparing the seminal fluid of normozoospermic and 
vasectomized men. The results indicate that the epididymis possesses region-specific
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antioxidant activity which may protect sperm from oxidative attack whilst stored at 
this site. In addition, the work has demonstrated that extra-epididymal storage of 
sperm is associated with spermatozoal damage, namely increased levels of chromatin 
damage, namely reduced protamine disulphide crosslinking, deficient chromatin 
condensation, and increased susceptibility to acid-induced denaturation, combined 
with a loss of cell motility.
CoQ10, a component of the respiratory chain and potent antioxidant, was quantified in 
spermatozoa and seminal plasma obtained from either smokers or non-smokers. It 
was hypothesised that levels of seminal CoQ10 might be lower in smokers' semen 
compared to non-smokers, due to the lower total antioxidant capacity that was 
previously determined in the smoker's group. Reduced CoQ10 levels may then 
explain, at least in part, the reduced spermatozoal motility observed in smokers 
compared to non-smokers due to energy deprivation. However, the amount of CoQ10 
in either the spermatozoa or seminal plasma was not different in specimens obtained 
from smokers and non-smokers. Spermatozoal levels of CoQ10 were, however, 
positively correlated with sperm count, motility and normal morphology.
The extraction of large volumes of semen using supercritical fluid followed by GC- 
MS analysis was performed in order to assess whether semen contains chemicals 
capable of causing damage to cells of the male and female reproductive tract. The 
extracts provided identification of nicotine and cotinine according to their mass 
spectra and retention times. Neither compound was detectable in the semen of non- 
smokers, concurring with the data obtained following supercritical extraction of small 
volumes of seminal fluid and subsequent chromatographic analysis using HPLC with
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UV detection. Caffeine was also detected in the seminal fluid of both smokers and 
non-smokers. The aromatic hydrocarbon, 1,2 benzenedicarboxylic acid, was also 
present in the semen of both smokers and non-smokers.
Supercritical fluid technology was also successfully applied to the extraction of 
caffeine and cotinine from seminal fluid. Specimens obtained from smokers 
contained detectable levels of cotinine; samples donated by non-smokers did not 
contain detectable amounts of cotinine. This data also validates the results gained 
during the study, for only semen that was obtained from men who declared to be 
smokers contained cotinine. Semen donated from individuals who reported that they 
were non-smokers, did not contain cotinine.
7.2 Discussion of Results
Cigarette smoking causes severe oxidative stress (Halliwell and Gutteridge, 1999). 
This study has demonstrated a reduction in seminal plasma antioxidant levels in the 
semen of men who smoke compared to those who do not. Lower antioxidant activity 
and seminal plasma oxidative stress have been associated with a reduction in sperm 
motility (Kobayashi et al., 1991; Aitken 1995; Geva et al., 1996; Suleiman et al., 
1996). A reduction in spermatozoal motility in smokers’ semen has been found in 
this and several other studies (Pacifici et al., 1993; Vine et al., 1994; Sofikitis et al., 
1995; Vine et al., 1996); the reduction may be as a direct consequence of the reduced 
abundance of antioxidants and subsequent higher levels of cellular oxidative stress. 
Low levels of seminal plasma antioxidants have also been associated with 
spermatozoal DNA damage (Fraga et al., 1991). Therefore, reduced seminal plasma
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antioxidant capacity, as demonstrated in men who smoked compared to those who did 
not, may indirectly lead to greater generation of DNA damage and possible 
mutagenesis.
Exposure of sperm to ROS can result in DNA damage, which is reduced by the 
presence of antioxidants and seminal plasma. Antioxidant levels in semen should, 
therefore, be maintained during the storage and manipulation of cells for in vitro 
fertility work, in order to reduce damage to the sperm.
The epididymis is known to act as the main site for the storage of sperm, whilst 
enabling the correct maturation of sperm (Hinton et al., 1995). It would seem from 
the results in the current study, that the epididymis also prevents the reduction of 
nuclear disulphide bonds and production of an abnormal chromatin structure. This 
may be partly due to the presence of antioxidants in the epididymal lumen itself, that 
was also demonstrated.
Epidemiological studies have implicated an association between paternal cigarette 
smoking and offspring pathology (Zhang et al., 1992; Sorahan et al., 1995; 1997a; 
1997b), in addition to an increased risk of cervical cancer in the partners of male 
smokers (Bosch et al., 1996). The presence of nicotine and cotinine in the seminal 
fluid of smokers has been confirmed previously (Pacifici et al., 1993). Both 
compounds are precursors of the mutagenic and carcinogenic nitrosamines. Although 
no known human mutagen or carcinogen has yet been discovered in semen, further 
work may positively identify such a compound. This would have important 
implications, not only to the production of spermatozoal DNA damage and mutations,
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but also to the possible association with male cigarette smoking and cervical cancer of 
their partners (Bosch et al., 1996).
The compound 1,2 benzenedicarboxylic acid, was detected using GC-MS after the 
extraction of semen with SFE. The aromatic nature of the compound hints towards its 
possible mutagenicity, akin to the mutagenicity and carcinogenicity of other aromatic 
compounds, such as PAH. It should be noted, however, that 1,2 benzenedicarboxylic 
acid is used in the synthesis of plastics (Standard ChemStation software 1996); thus, 
the notion that the compound is a component of the plastic containers used for the 
storage of semen, and does not actually reside in the seminal fluid itself, should be 
borne in mind.
7.3 Future Work
The greater damage observed in the chromatin of sperm from smokers compared to 
non-smokers requires future consideration. Potential correlations with DNA damage, 
frequencies of sperm aneuploidy, seminal plasma antioxidants, and cigarette 
consumption according to plasma cotinine concentration, for example, should be 
evaluated. The frequencies of aneuploidy should be determined for chromosomes not 
examined in the current study in a broad cross section of men, such as those of low 
fertility, smokers or heavy consumers of caffeine. Additionally, future studies should 
attempt to control in each experiment variables that exist in the semen donors. For 
example, donor age, use of pharmaceuticals, and cigarette, caffeine and alcohol 
consumption.
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We have indicated an association of smoking with sperm mutations, namely YY1 
aneuploidy. Future studies should assess whether smoking causes further germline 
mutations, which may lead to birth defects and genetic disease in offspring. Certain 
epidemiological studies indicate that this may be the case (Zhang et al., 1992; 
Sorahan et aL, 1995; 1997a; 1997b). In addition, modem analytical techniques 
should be used to determine whether mutagenic and carcinogenic compounds and/or 
their metabolites, such as TSNA and PAH, are present in seminal plasma. The 
measurement of DNA adducts of such chemicals should also be rigorously 
undertaken, in order to provide estimations of the possible incidence of germline 
mutations. Relationships with smoking status and antioxidant concentrations, if 
present, should be established.
Regarding the protective effect of seminal plasma on spermatozoa, future work 
should determine whether the protection afforded by seminal plasma is correlated 
with its antioxidant properties. In addition, whether certain populations, such as 
smokers and men of low fertility, individuals that possess lower plasma antioxidant 
levels and higher levels of DNA damage, are more susceptible to the effects of 
oxidative damage should be addressed.
Associations with smoking and male fertility requires further investigation. Several 
studies have correlated cigarette consumption with a reduction in sperm count and 
motility and an increase in the number of abnormal cells (Pacifici et al., 1993; Vine et 
al., 1994; Sofikitis et al., 1995; Vine et al., 1996). Data should be collected to assess 
whether smokers have greater difficulty conceiving than non-smokers, both during in 
vitro fertilisation work and in vivo. Research should be performed to determine
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whether men who are of low fertility and/or low in plasma antioxidants, are able to 
improve their chances of parenthood through cessation of smoking or by increasing 
their plasma antioxidant levels, for example, by raising dietary intake of such 
compounds.
Although we feel that the conclusions reached in the present study are justified, an 
important qualification is emphasised. Our samples of normozoospermic semen were 
obtained from the male partners of infertile couples and it remains largely unknown to 
what extent these are truly normal; i.e. comparable to that in normozoospermic men 
of proven fertility. It is possible, for example, that samples from men who have 
conceived and are, therefore, of proven fertility, would provide differing results as to 
those found in this study. For instance, sperm obtained from men of proven fertility 
might show even more extreme differences than that observed when 
‘normozoospermic’ sperm were compared with spermatozoa from men post­
vasectomy. It will be of importance in future studies to test whether the results found 
in this study remain true in samples obtained from men of proven fertility.
In conclusion, this study has discovered several novel findings that may have 
important implications for male reproductive toxicology. The reduction in human 
semen quality, that appears to be occurring currently and through the last century 
(Carlsen et al., 1992), has prompted the need for a more extensive knowledge of the 
male reproductive system. In particular, further information regarding compounds 
that are capable of being beneficial or detrimental to male fertility is required. 
Additionally, more sensitive and specific laboratory assays and increased sample 
sizes should be used to establish whether certain factors, such as oxidative stress and
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toxic chemicals, induce sperm mutations which may result in birth defects and genetic 
disease in offspring. This would then allow suitable recommendations and safety 
precautions to be put into place, so as to protect human populations. A thorough 
evaluation of potential adverse effects on male reproduction should be included in 
drug developmental studies. It is hoped that this study will add significantly to the 
information currently available in this area, and lead to more effective methods for 
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